Processing 00000000.tx.1: Accumulation of high-molecular-weight amylose in Alzheimer's disease brains Linjuan Huang2, Rawle I. 

Phrase: "Accumulation of high-molecular-weight amylose"

Phrase: "in Alzheimer's disease brains Linjuan Huang2,"

Phrase: "Rawle I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: Hollingsworth3, Rudy Castellani4 and Birgit Zipser1,2 2 Department of Physiology, 2195 Biomedical and Physical Sciences Bldg., Michigan State University, East Lansing, MI 48824; 

Phrase: "Hollingsworth3,"

Phrase: "Rudy Castellani4"

Phrase: "and"

Phrase: "Birgit Zipser1,"

Phrase: "2 2 Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "2195 Biomedical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879848:Biomedical [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Physical Sciences Bldg.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0031816:Physical Sciences [Occupation or Discipline]

Phrase: "Michigan State University,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025939:Michigan [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "East Lansing,"

Phrase: "MI 48824"

Phrase: ";"
Processing 00000000.tx.3: 3 Department of Biochemistry, Michigan State University, East Lansing, MI 48824; 

Phrase: "3 Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Michigan State University,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025939:Michigan [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "East Lansing,"

Phrase: "MI 48824"

Phrase: ";"
Processing 00000000.tx.4: and 4 Department of Physiology, Division of Pathology, Michigan State University, East Lansing, MI 48824 Received on July 29, 2003; 

Phrase: "and"

Phrase: "4 Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Division of Pathology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "Michigan State University,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025939:Michigan [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "East Lansing,"

Phrase: "MI 48824"

Phrase: "Received on July 29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514756:Received [Qualitative Concept]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.5: revised on October 27, 2003; 

Phrase: "revised on October 27,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1527075:Revised [Therapeutic or Preventive Procedure]
   737 E C3244319:revise [Functional Concept]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.6: accepted on November 28, 2003  Abstract Top Abstract Introduction Results Discussion Materials and methods References  Although most of the glucose metabolized in the brain is taken up from the blood, glucose derived from glycogen stores is increasingly implicated in both normal brain function and injury repair. 

Phrase: "accepted on November 28,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1272684:Accepted [Qualitative Concept]
   770   C1548435:Accepted [Idea or Concept]
   737 E C1548601:Accept [Idea or Concept]

Phrase: "2003  Abstract Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "most of the glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205393:Most [Quantitative Concept]

Phrase: "metabolized in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1524026:Metabolized [Cell Function]

Phrase: "is"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "from the blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "derived from glycogen stores"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737   C1698986:Store [Functional Concept]

Phrase: "is"

Phrase: "increasingly"

Phrase: "implicated in both normal brain function"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0678908:brain function [Organ or Tissue Function]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0031843:function [Physiologic Function]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1705273:Function [Intellectual Product]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "injury repair."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043240:Repair, NOS [Organism Function]
   861   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: An impaired glucose metabolism is one of the features of Alzheimer's disease (AD) entailing a reduction in glucose transporters and the uptake of glucose as well as alterations in the specific activity of glycolytic enzymes. 

Phrase: "An impaired glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "one of the features of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "(AD) entailing"

Phrase: "a reduction in glucose transporters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the uptake of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1159527:glucose uptake [Cell Function]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "as well as"

Phrase: "alterations in the specific activity of glycolytic enzymes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1516891:Enzyme Activity Alteration [Physiologic Function]
   750   C0184517:Activity alteration [Finding]
   711   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.8: Here we report that AD brains accumulate amylose, the unbranched (1,4)-linked glucose polymer that is resistant to degradation by glycolytic enzymes. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "accumulate"

Phrase: "amylose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "the unbranched"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4"

Phrase: ")-"

Phrase: "linked glucose polymer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   727 E C1218520:Polymeria [Plant]

Phrase: "that"

Phrase: "is"

Phrase: "resistant to degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "by glycolytic enzymes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
   789   C0017952:Glycolysis [Molecular Function]
Processing 00000000.tx.9: Neutral polysaccharides harvested from postmortem brains were purified with hydrazinolysis, ion exchange, and sizing chromatography and subjected to NMR spectroscopy, GC, GC-MS, and methylation analysis. 

Phrase: "Neutral polysaccharides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   827 E C2348281:Polysaccharide [Carbohydrate]

Phrase: "harvested from postmortem brains"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0004398:postmortem [Diagnostic Procedure]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0580205:Postmortem [Temporal Concept]
   770   C0848632:post mortem [Finding]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "were"

Phrase: "purified with hydrazinolysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1998793:Purified [Functional Concept]

Phrase: "ion exchange,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022013:Ion Exchange [Molecular Function]
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C0678640:exchange [Social Behavior]
   861   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "sizing chromatography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0008550:Chromatography [Laboratory Procedure]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "and"

Phrase: "subjected to NMR spectroscopy,"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   882   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   833   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   833   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   833   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   833   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   790   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   790   C1551403:Magnetic resonance [Laboratory Procedure]
   753   C0024488:Magnetic [Occupation or Discipline]
   753   C0037812:spectroscopy [Laboratory Procedure]
   753   C0231881:Resonance [Finding]
   753   C0459800:resonance [Natural Phenomenon or Process]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0563532:magnetic [Natural Phenomenon or Process]
   753   C0684213:Resonance [Qualitative Concept]
   753   C2713504:Spectroscopy [Occupation or Discipline]
   753   C2984732:SPECTROSCOPY [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "GC,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008555:Gas Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C0017110:Gas [Chemical Viewed Structurally]
   861   C0596601:Gas [Sign or Symptom]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "GC-MS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]
   734   C0008555:Gas Chromatography [Laboratory Procedure]

Phrase: "and"

Phrase: "methylation analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.10: Five percent of the polysaccharides (50 g [0.3 mol]/g wet weight brain tissue) consisted of amylose with molecular weights exceeding 600,000 Da. 

Phrase: "Five percent of the polysaccharides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "(50 g [0.3 mol"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   875   C2348885:g/mol [Quantitative Concept]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: "]/g wet weight brain tissue"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0006114:wet brain [Pathologic Function]
   853   C1527311:wet brain [Disease or Syndrome]
   840   C0440746:Brain tissue [Tissue]
   840   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0040300:Tissue [Tissue]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1547928:Tissue [Intellectual Product]

Phrase: ")"

Phrase: "consisted of amylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0002732:Amylose [Carbohydrate]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "with molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "exceeding"

Phrase: "600,000 Da."
Processing 00000000.tx.11: There is no evidence for 1,6-branching, indicating that the polymer is not a form of high-molecular-weight glycogen. 

Phrase: "There"

Phrase: "is"

Phrase: "no evidence for 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "6-branching,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205384:Branching [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a form of high-molecular-weight glycogen."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
Processing 00000000.tx.12: By GC analysis, the glucose content of the AD brains was almost three times greater than that of the age-matched control brains. 

Phrase: "By GC analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0008555:Gas Chromatography [Laboratory Procedure]

Phrase: "the glucose content of the AD brains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "almost three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "greater than that of the age-matched control brains."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C0439093:Greater Than [Quantitative Concept]
   742   C0443228:greater [Quantitative Concept]
   742   C1704243:Greater [Quantitative Concept]
   708 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.13: A synthesis of amylose in AD brains at the expense of glycogen would compromise glucose metabolism and enhance neural degeneration. 

Phrase: "A synthesis of amylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "in AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "at the expense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680864:expense [Quantitative Concept]

Phrase: "of glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "would"

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "neural degeneration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027746:neural degeneration [Cell or Molecular Dysfunction]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.14: Key words: corpora amylacea / glucose metabolism / glycogen stores / glycogen storage disease / glycopathobiochemistry  Introduction Top Abstract Introduction Results Discussion Materials and methods References  Glucose metabolism during normal brain function and neurodegenerative disease is a field of active research. 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "corpora amylacea / glucose metabolism / glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1698986:Store [Functional Concept]

Phrase: "/ glycogen storage disease / glycopathobiochemistry  Introduction Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glucose metabolism during normal brain function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0596620:glucose metabolism [Molecular Function]
   783   C0596215:brain metabolism [Organ or Tissue Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "neurodegenerative disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a field of active research."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0683945:field research [Research Activity]
   760   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   760   C1521738:Field [Conceptual Entity]
   760   C2346620:Field [Conceptual Entity]
   760   C2349184:Field [Conceptual Entity]
   760   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.15: Although most of the consumed glucose is taken up from the blood, evidence is accumulating that brain glycogen is also an important energy source (Choi et al., 2003). 

Phrase: "Although"

Phrase: "most of the consumed glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205393:Most [Quantitative Concept]

Phrase: "is"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "from the blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "accumulating"

Phrase: "that brain glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "is"

Phrase: "also"

Phrase: "an important energy source"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0014275:energy source [Functional Concept]
   827   C0449416:Source [Finding]
   827   C1705919:Source [Idea or Concept]

Phrase: "(Choi et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.16: Glucose metabolism has commonly been measured using the uptake of a radiolabeled deoxyglucose, an inert glucose analog (Rapoport, 1999) and more recently of radiolabeled glucose (Hampel et al., 2002). 

Phrase: "Glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "has"

Phrase: "commonly"

Phrase: "been"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the uptake of a radiolabeled deoxyglucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "an inert glucose analog"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0596619:glucose analog [Carbohydrate]
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "(Rapoport,"

Phrase: "1999"

Phrase: ")"

Phrase: "and"

Phrase: "more recently of radiolabeled glucose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205172:More [Functional Concept]
   760   C0332185:Recently [Temporal Concept]
   760   C1527121:Radiolabeled [Qualitative Concept]
   726 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Hampel et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.17: Ultrastructural studies demonstrated that glycogen is primarily located in astrocytes, although neuronal, ependymal, and choroid plexus cells contain small amounts as well (Magistretti et al., 1993; Peters et al., 1970). 

Phrase: "Ultrastructural studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789   C0041623:Ultrastructure [Idea or Concept]

Phrase: "demonstrated"

Phrase: "that glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "is"

Phrase: "primarily"

Phrase: "located in astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004112:Astrocytes [Cell]

Phrase: "although"

Phrase: "neuronal, ependymal,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521405:Ependymal [Body Location or Region]
   789 E C0014472:Ependyma [Tissue]

Phrase: "and"

Phrase: "choroid plexus cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0008524:Choroid Plexus [Body Part, Organ, or Organ Component]
   734   C1280704:Choroid plexus [Body Part, Organ, or Organ Component]
   734   C2326827:Chorioid plexus [Anatomical Structure]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "small amounts as well"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(Magistretti et al.,"

Phrase: "1993"

Phrase: "; Peters et al.,"

Phrase: "1970"

Phrase: ")."
Processing 00000000.tx.18: It has been difficult to visualize or quantify brain glycogen because of its rapid postmortem degradation. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "visualize"

Phrase: "or"

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "brain glycogen because of its rapid postmortem degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0596624:glycogen degradation [Molecular Function]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.19: However, glycogen levels as high as 12 mol/g have been found using new protocols involving the extraction of glycogen and the handling of animals with minimal environmental stimuli (Cruz and Dienel, 2002). 

Phrase: "However,"

Phrase: "glycogen levels as high"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "as 12 mol/g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2347285:mol/g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "new protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the extraction of glycogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "the handling of animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018578:Handling [Behavior]
   770   C1832073:Handling [Finding]

Phrase: "with minimal environmental stimuli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0450025:Environmental stimuli [Natural Phenomenon or Process]
   827   C0234402:Stimuli [Phenomenon or Process]

Phrase: "(Cruz"

Phrase: "and"

Phrase: "Dienel,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.20: Furthermore, light microscopic analysis demonstrated that axonal tracts contain higher glycogen levels than neuropil regions (Kong et al., 2002). 

Phrase: "Furthermore,"

Phrase: "light microscopic analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "that axonal tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "higher glycogen levels than neuropil regions"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0441889:Levels [Qualitative Concept]
   725   C0683928:regional level [Spatial Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Kong et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.21: Alterations in glucose metabolism are found in various disease states. 

Phrase: "Alterations in glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   991   C0744434:Alteration in glucose metabolism [Finding]
   870   C1382395:Glucose Metabolism Alteration [Organ or Tissue Function]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "are"

Phrase: "found in various disease states."
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   760   C0012634:Disease [Disease or Syndrome]
   760   C0150312:Found [Quantitative Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1301808:states [Geographic Area]
   726 E C0243095:Find [Finding]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.22: During ischemia, both astrocytes and microglia exhibit an increase in glucose uptake and glycogen storage (Kajihara et al., 2001). 

Phrase: "During ischemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "both astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "microglia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206116:Microglia [Cell]
   928 E C0521398:Microglial [Body Location or Region]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an increase in glucose uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "glycogen storage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337174:Storage [Spatial Concept]
   861   C1698986:Storage [Functional Concept]
   861   C1753314:storage [Cell Component]

Phrase: "(Kajihara et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.23: In epileptic brains, astrocytes exhibit intense dehydrogenase activity, stopping at the amylose step in the synthesis of glycogen. 

Phrase: "In epileptic brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "intense dehydrogenase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "stopping at the amylose"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0002732:Amylose [Carbohydrate]
   770   C0723457:stopping [Inorganic Chemical,Pharmacologic Substance]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]

Phrase: "step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "the synthesis of glycogen."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1157202:glycogen synthesis [Molecular Function]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]
Processing 00000000.tx.24: This decreased dehydrogenase activity resulted in an accumulation of amylose, the unbranched (1,4)-linked glucose polymer (Gilles-Pierlet, 1980). 

Phrase: "This decreased dehydrogenase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0086439:Decreased activity [Sign or Symptom]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "resulted in an accumulation of amylose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002732:Amylose [Carbohydrate]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "the unbranched"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4"

Phrase: ")-"

Phrase: "linked glucose polymer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   727 E C1218520:Polymeria [Plant]

Phrase: "(Gilles-Pierlet,"

Phrase: "1980"

Phrase: ")."
Processing 00000000.tx.25: Amylose is also generated in type IV glycogen storage disease due to the lack in branching enzyme (as reviewed in Cavanagh, 1999). 

Phrase: "Amylose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "is"

Phrase: "also"

Phrase: "generated in type IV glycogen storage disease"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   897   C0017923:Glycogen storage disease, type IV [Disease or Syndrome]
           GLYCOGEN STORAGE DISEASE IV
   870 E C1415001:glycogen storage disease type IV [Gene or Genome]
   814   C0017919:Glycogen Storage Disease [Disease or Syndrome]
   778   C0267971:Storage disease [Disease or Syndrome]
   778   C0441732:Type IV [Classification]
   774   C0457464:disease type [Intellectual Product]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0332307:Type [Qualitative Concept]
   748   C0337174:Storage [Spatial Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1698986:Storage [Functional Concept]
   748   C1753314:storage [Cell Component]
   748   C3146294:Generated [Activity]

Phrase: "due to the lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "in branching enzyme"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0000052:Branching Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205384:Branching [Spatial Concept]
   827 E C1253959:Branch [Body Part, Organ, or Organ Component]
   827 E C1881507:Branch [Chemical Viewed Structurally]
   827 E C2700383:Branch [Plant]
   827 E C2826234:BRANCH [Intellectual Product]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "reviewed in Cavanagh,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.26: Amylose, in contrast to glycogen, is not a readily accessible source of energy because it is resistant to degradation by enzymes endogenous to the brain that break down glycogen. 

Phrase: "Amylose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "in contrast to glycogen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a readily accessible source of energy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0449417:Source of energy [Finding]
   783   C0014275:energy source [Functional Concept]
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "resistant to degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "by enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "endogenous to the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205227:Endogenous [Functional Concept]

Phrase: "that break down glycogen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   734   C0443161:break down [Qualitative Concept]
Processing 00000000.tx.27: During normal aging, glucose polymers, considered to be amylose, accumulate in corpora amylacea (starch bodies) in the glial feltwork on brain surfaces, which so far have not been reported to contribute to cognitive decline. 

Phrase: "During normal aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "glucose polymers,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0017696:glucose polymers [Carbohydrate,Pharmacologic Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   755 E C1218520:Polymeria [Plant]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "amylose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "accumulate in corpora amylacea"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0333564:Corpora amylacea [Pathologic Function]
   833   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   737   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "(starch bodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ")"

Phrase: "in the glial feltwork"

Phrase: "on brain surfaces,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1283379:Brain surface [Body Location or Region]
   827   C0205148:Surface [Spatial Concept]

Phrase: "which so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to cognitive decline."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C1516691:Cognitive [Functional Concept]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.28: In Alzheimer's disease (AD), cognitive decline is paralleled by a reduction in cerebral blood flow and glucose metabolism. 

Phrase: "In Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "paralleled by a reduction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   737   C2348042:Parallel [Qualitative Concept]
   737   C2826345:PARALLEL [Research Activity]

Phrase: "in cerebral blood flow"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
  1000   C0007818:Cerebral Blood Flow [Organ or Tissue Function]
  1000   C0373440:cerebral blood flow [Diagnostic Procedure]
   901   C0232338:Blood flow [Organism Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.29: Other signs of impaired glucose metabolism reported for AD brains include the altered activity of glycolytic enzymes (Bigl et al., 1999) and alteration in insulin levels and insulin resistance (as reviewed in Watson and Craft, 2003). 

Phrase: "Other signs of impaired glucose metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0220912:signs [Functional Concept]
   753   C0220913:signs [Manufactured Object]
   753   C0311392:SIGNS [Finding]
   719 E C1547188:Sign [Idea or Concept]

Phrase: "reported for AD brains"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C3273238:Report [Intellectual Product]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the altered activity of glycolytic enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0243102:enzyme activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Bigl et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "and"

Phrase: "alteration in insulin levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "reviewed in Watson"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   790   C3476816:Watson [Quantitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Craft,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870369:craft [Manufactured Object]

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.30: In this study, we purified amylose, the unbranched (1,4)-linked glucose polymer, from AD brains. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "amylose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "the unbranched"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4"

Phrase: ")-"

Phrase: "linked glucose polymer,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   727 E C1218520:Polymeria [Plant]

Phrase: "from AD brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.31: Amylose occurs in two size populations, with molecular weights of about 600,000 Da and more than 1,000,000 Da. 

Phrase: "Amylose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "occurs in two size populations,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0032683:Population Size [Quantitative Concept]
   760   C0032659:Population [Quantitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0456389:size [Spatial Concept]
   760   C1257890:Population [Population Group]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "with molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "of about 600,000 Da"

Phrase: "and"

Phrase: "more than 1,000,000 Da."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205172:More [Functional Concept]
Processing 00000000.tx.32: Thus by its high molecular weight, AD amylose differs from the glucose polymers (<4,000 Da) that are encapsulated in corpora amylacea during normal aging. 

Phrase: "Thus by its high molecular weight, AD amylose"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C1979900:High molecular weight [Qualitative Concept]
   770   C0026385:Molecular Weight [Quantitative Concept]
   767   C0948775:high weight [Sign or Symptom]
   744   C0002732:Amylose [Carbohydrate]
   744   C0005910:weight [Organism Attribute]
   744   C0043100:Weight [Quantitative Concept]
   744   C0205250:High [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1705104:Weight [Idea or Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "differs from the glucose polymers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0017696:glucose polymers [Carbohydrate,Pharmacologic Substance]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]

Phrase: "("

Phrase: "<4,000 Da)"

Phrase: "that"

Phrase: "are"

Phrase: "encapsulated in corpora amylacea"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0333564:Corpora amylacea [Pathologic Function]
   833   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   770   C0205223:Encapsulated [Qualitative Concept]
   770   C1333381:encapsulated [Finding]
   737   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "during normal aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]
Processing 00000000.tx.33: The synthesis of amylose in AD brains at the expense of glycogen may partly explain metabolic compromises leading to the neurodegeneration in AD.  

Phrase: "The synthesis of amylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "in AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "at the expense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680864:expense [Quantitative Concept]

Phrase: "of glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "may"

Phrase: "partly"

Phrase: "explain"

Phrase: "metabolic compromises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945640:compromises [Finding]

Phrase: "leading to the neurodegeneration"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in AD."
Processing 00000000.tx.34: Results Top Abstract Introduction Results Discussion Materials and methods References  Glucose polymers were isolated from human brain material. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glucose polymers"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0017696:glucose polymers [Carbohydrate,Pharmacologic Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   755 E C1218520:Polymeria [Plant]

Phrase: "were"

Phrase: "isolated from human brain material."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   797   C0440470:Human material [Body Substance]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C0205409:Isolated [Functional Concept]
   760   C0520510:Material [Substance]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.35: Cerebral cortices were obtained at autopsy from three advanced AD cases (7983 years; 

Phrase: "Cerebral cortices"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cortices, Cerebral [Body Part, Organ, or Organ Component]
           Cortex
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "obtained at autopsy"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0004398:Autopsy [Diagnostic Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from three advanced AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "(7983 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.36: postmortem interval: 69 h) and three nondemented, age-matched control cases (6790 years; 

Phrase: "postmortem interval"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: ":"

Phrase: "69 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "three nondemented, age-matched control cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "(6790 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.37: postmortem interval: 4.515 h). 

Phrase: "postmortem interval"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: ":"

Phrase: "4.515 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.38: Each cortical material was separately fractionated using three successive Bio-Gel size exclusion chromatographies: Bio-Gel P4, Bio-Gel P10, and Bio-Gel P60. 

Phrase: "Each cortical material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "separately"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "three successive Bio-Gel size exclusion chromatographies"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   829   C0008559:Gel Chromatography [Laboratory Procedure]
           Size Exclusion Chromatography
           Chromatography, Exclusion
   812   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   795   C0008550:Chromatographies [Laboratory Procedure]
   795   C0456389:size [Spatial Concept]
   795   C0680251:EXCLUSION [Functional Concept]
   795   C2828389:Exclusion [Activity]

Phrase: ":"

Phrase: "Bio-Gel P4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1539372:p4 [Gene or Genome]

Phrase: "Bio-Gel P10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0966870:p10 [Amino Acid, Peptide, or Protein,Receptor]
   827   C1425194:p10 [Gene or Genome]
   827   C1548702:P10 [Intellectual Product]

Phrase: "and"

Phrase: "Bio-Gel P60."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3539537:p60 [Gene or Genome]
   827   C3540648:p60 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.39: Gel filtration chromatography on a Bio-Gel P4 column of delipidated, hydrazinolyzed material from AD and control tissues gave polysaccharide peaks in the exclusion volume (Figure 1A, B, arrows) as judged by resonance between 3.0 ppm and 5.5 ppm (Figure 2) and by compositional analysis using gas chromatography (GC) (Table I). 

Phrase: "Gel filtration chromatography on a Bio-Gel P4 column"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Filtration
           Gel Chromatography
   762   C0684296:Chromatography.column [Laboratory Procedure]
   742   C0008550:Chromatography [Laboratory Procedure]
   742   C0016107:filtration [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C1382104:Gel [Substance]

Phrase: "of delipidated, hydrazinolyzed material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "from AD"

Phrase: "and"

Phrase: "control tissues"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0040300:Tissues [Tissue]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "polysaccharide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032594:Polysaccharide [Carbohydrate,Pharmacologic Substance]
  1000   C2348281:Polysaccharide [Carbohydrate]

Phrase: "peaks in the exclusion volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0444505:Peak [Quantitative Concept]
   760   C0449468:*Volume [Quantitative Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]
   760   C2828389:Exclusion [Activity]

Phrase: "(Figure 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "as"

Phrase: "judged by resonance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0231881:Resonance [Finding]
   790   C0459800:resonance [Natural Phenomenon or Process]
   790   C0684213:Resonance [Qualitative Concept]
   756   C0221191:Judge [Professional or Occupational Group]
   718 E C0577554:Resonant [Qualitative Concept]

Phrase: "between 3.0 ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439187:ppm [Quantitative Concept]

Phrase: "and"

Phrase: "5.5 ppm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439187:ppm [Quantitative Concept]
   734   C0450380:5/5 [Quantitative Concept]

Phrase: "(Figure 2"

Phrase: ")"

Phrase: "and by compositional analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1515981:And [Idea or Concept]
   770   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "gas chromatography (GC)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008555:Gas Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C0017110:Gas [Chemical Viewed Structurally]
   861   C0596601:Gas [Sign or Symptom]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.40: The average percentage of polysaccharide/wet weight tissue (or delipidated tissue) was 0.063% (or 1%) and 0.029% (or 0.5%) for AD and control cerebral cortices, respectively. 

Phrase: "The average percentage of polysaccharide/wet weight tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439165:Percentage [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]

Phrase: "("

Phrase: "or"

Phrase: "delipidated tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "0.063%"

Phrase: "("

Phrase: "or"

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "0.029%"

Phrase: "("

Phrase: "or"

Phrase: "0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "for AD"

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cerebral cortices,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cortices, Cerebral [Body Part, Organ, or Organ Component]
           Cortex
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "respectively."
Processing 00000000.tx.41: The anomeric proton area of the proton spectra of the polysaccharides from AD brains contained a large resonance at 5.4 ppm, indicative of an anomeric proton that was lacking in the age-matched control brains (Figure 2A arrow, 2B). 

Phrase: "The anomeric proton area of the proton spectra of the polysaccharides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0017446:Area [Geographic Area]
   738   C0205146:Area [Spatial Concept]

Phrase: "from AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a large resonance at 5.4 ppm,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0231881:Resonance [Finding]
   748   C0459800:resonance [Natural Phenomenon or Process]
   748   C0684213:Resonance [Qualitative Concept]

Phrase: "indicative of an anomeric proton"

Phrase: "that"

Phrase: "was"

Phrase: "lacking in the age-matched control brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:Lacking [Qualitative Concept]

Phrase: "(Figure 2A arrow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336721:Arrow [Manufactured Object]

Phrase: "2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.42: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.43: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.44: Size chromatography profiles of neutral glycans on a Bio-Gel P4 column. 

Phrase: "Size chromatography profiles of neutral glycans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "on a Bio-Gel P4 column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]
Processing 00000000.tx.45: (A) Glycans from a 70-year-old AD brain. 

Phrase: "(A) Glycans from a 70-year-old AD brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.46: (B) Glycans from a 90-year-old control brain. 

Phrase: "(B) Glycans from a 90-year-old control brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.47: The arrows indicate polysaccharide peaks in the exclusion volume. 

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "polysaccharide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032594:Polysaccharide [Carbohydrate,Pharmacologic Substance]
  1000   C2348281:Polysaccharide [Carbohydrate]

Phrase: "peaks in the exclusion volume."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0444505:Peak [Quantitative Concept]
   760   C0449468:*Volume [Quantitative Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]
   760   C2828389:Exclusion [Activity]
Processing 00000000.tx.48: Flow rate: 0.2 ml/min, 1.6 ml/tube.  

Phrase: "Flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: ":"

Phrase: "0.2 ml/min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439445:mL/min [Quantitative Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "1.6 ml/tube."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175730:Tube [Medical Device]
   812   C1547937:Tube NOS [Intellectual Product]
   812   C1561954:tube [Conceptual Entity]
   812   C1704730:TUBE [Medical Device]
Processing 00000000.tx.49: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.50: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.51: Expanded region of 500 MHz 1H NMR spectra of neutral polysaccharides separated from oligosaccharides using Bio-Gel P4 chromatography. 

Phrase: "Expanded region of 500 MHz 1H NMR spectra of neutral polysaccharides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0017446:Region [Geographic Area]
   735   C0205147:Region [Spatial Concept]

Phrase: "separated from oligosaccharides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028959:Oligosaccharides [Carbohydrate]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Bio-Gel P4 chromatography."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C0008559:Gel Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   712 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.52: (A) Polysaccharides from an AD brain. 

Phrase: "(A) Polysaccharides from an AD brain."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   719 E C2348281:Polysaccharide [Carbohydrate]
Processing 00000000.tx.53: The arrow indicates a prominent resonance at 5.4 ppm. 

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "a prominent resonance at 5.4 ppm."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0231881:Resonance [Finding]
   748   C0459800:resonance [Natural Phenomenon or Process]
   748   C0684213:Resonance [Qualitative Concept]
Processing 00000000.tx.54: (B) Polysaccharides from an aged control brain. 

Phrase: "(B) Polysaccharides from an aged control brain."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   714 E C2348281:Polysaccharide [Carbohydrate]
Processing 00000000.tx.55: Spectra were recorded in D2O solution at 50C. 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded in D2O solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]
   737   C0034869:Record [Intellectual Product]

Phrase: "at 50C."
Processing 00000000.tx.56: Chemical shifts are expressed in ppm from acetone (2.225 ppm).  

Phrase: "Chemical shifts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220806:Chemical [Chemical]
   861   C0333051:shifts [Functional Concept]
   861   C3272558:Chemical [Intellectual Product]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "are"

Phrase: "expressed in ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439187:ppm [Quantitative Concept]

Phrase: "from acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: "(2.225 ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439187:ppm [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.57: View this table: [in this window] [in a new window]  Table I. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.58: Compositional analysis by GC spectrometry of neutral polysaccharides from aged control and AD cerebral cortices after Bio-Gel P4 size chromatography  The compositions of the polysaccharide peaks from the six different brain samples as determined by GC analysis is shown in Table I. 

Phrase: "Compositional analysis by GC spectrometry of neutral polysaccharides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "from aged control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "AD cerebral cortices after Bio-Gel P4 size chromatography"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0007776:Cortices, Cerebral [Body Part, Organ, or Organ Component]
           Cortex
   708   C1176472:Cortex [Body Part, Organ, or Organ Component]
   708   C2700441:Cortex [Plant]

Phrase: "The compositions of the polysaccharide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0486616:compositions [Clinical Attribute]
   726 E C1555710:composition [Idea or Concept]

Phrase: "peaks from the six different brain samples"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0205452:Six [Quantitative Concept]
   748   C0444505:Peak [Quantitative Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1705242:Different [Qualitative Concept]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "as"

Phrase: "determined by GC analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0008555:Gas Chromatography [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0017110:Gas [Chemical Viewed Structurally]
   760   C0596601:Gas [Sign or Symptom]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "shown in Table I."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.59: The average glucose content of the polysaccharides purified from AD cerebral cortices was three times higher than that of the control cortices. 

Phrase: "The average glucose content of the polysaccharides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "purified from AD cerebral cortices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cortices, Cerebral [Body Part, Organ, or Organ Component]
           Cortex
   760   C1998793:Purified [Functional Concept]
   726   C1176472:Cortex [Body Part, Organ, or Organ Component]
   726   C2700441:Cortex [Plant]

Phrase: "was"

Phrase: "three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "higher than that of the control cortices."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.60: To investigate the origin of the resonance seen at 5.4 ppm in the NMR spectrum of the AD polysaccharides, the polysaccharides were subjected to further size fractionations. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the origin of the resonance"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0079946:origin [Classification]
   760   C0439659:Origin [Temporal Concept]
   760   C1550512:origin [Intellectual Product]
   704 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   704 E C0314603:Genetic [Functional Concept]

Phrase: "seen at 5.4 ppm"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0205397:Seen [Qualitative Concept]
   760   C0439187:ppm [Quantitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "in the NMR spectrum"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   923   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   923   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   923   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   861   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   861   C1551403:Magnetic resonance [Laboratory Procedure]
   812   C0024488:Magnetic [Occupation or Discipline]
   812   C0231881:Resonance [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0563532:magnetic [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1883073:Spectrum [Quantitative Concept]
   812   C2827424:Spectrum [Conceptual Entity]
   741 E C0024483:Magnet [Manufactured Object]
   741 E C0577554:Resonant [Qualitative Concept]
   741 E C0885556:magnets [Pharmacologic Substance]
   741 E C1706318:Magnet [Manufactured Object]

Phrase: "of the AD polysaccharides,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   827 E C2348281:Polysaccharide [Carbohydrate]

Phrase: "the polysaccharides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   966 E C2348281:Polysaccharide [Carbohydrate]

Phrase: "were"

Phrase: "subjected to further size fractionations."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0456389:size [Spatial Concept]
   760   C1517331:Further [Spatial Concept]
   726   C0016640:fractionation [Laboratory Procedure]
   726 E C0205108:far [Spatial Concept]
   726   C0524811:fractionation [Therapeutic or Preventive Procedure]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
   726   C3161031:Fractionation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.61: Bio-Gel P10 sizing chromatography yielded three peaks (Figure 3A). 

Phrase: "Bio-Gel P10 sizing chromatography"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C0008559:Gel Chromatography [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "yielded"

Phrase: "three peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "(Figure 3A"

Phrase: ")."
Processing 00000000.tx.62: Examining each of these peaks by 1D 1H nuclear magnetic resonance (NMR) spectroscopy demonstrated that the 5.4 ppm resonance was obtained only from peak I. 

Phrase: "Examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "each of these peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444505:peaks [Quantitative Concept]
   770   C1457900:Each [Quantitative Concept]

Phrase: "by 1D 1H nuclear magnetic resonance (NMR) spectroscopy"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   861   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   861   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   861   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   861   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   827   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   827   C1551403:Magnetic resonance [Laboratory Procedure]
   799   C0024488:Magnetic [Occupation or Discipline]
   799   C0037812:spectroscopy [Laboratory Procedure]
   799   C0231881:Resonance [Finding]
   799   C0459800:resonance [Natural Phenomenon or Process]
   799   C0521447:Nuclear [Spatial Concept]
   799   C0563532:magnetic [Natural Phenomenon or Process]
   799   C0684213:Resonance [Qualitative Concept]
   799   C2713504:Spectroscopy [Occupation or Discipline]
   799   C2984732:SPECTROSCOPY [Functional Concept]
   727 E C0024483:Magnet [Manufactured Object]
   727 E C0577554:Resonant [Qualitative Concept]
   727 E C0885556:magnets [Pharmacologic Substance]
   727 E C1706318:Magnet [Manufactured Object]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the 5.4 ppm resonance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0231881:Resonance [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "only from peak I."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0205171:Only [Quantitative Concept]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0444505:Peak [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
Processing 00000000.tx.63: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.64: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.65: Size chromatography profiles of neutral polysaccharides from an AD brain using Bio-Gel P10 and P60 columns. 

Phrase: "Size chromatography profiles of neutral polysaccharides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "from an AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Bio-Gel P10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0966870:p10 [Amino Acid, Peptide, or Protein,Receptor]
   827   C1425194:p10 [Gene or Genome]
   827   C1548702:P10 [Intellectual Product]

Phrase: "and"

Phrase: "P60 columns."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]
Processing 00000000.tx.66: (A) First, using Bio-Gel P10 chromatography, an AD polysaccharide fraction from a Bio-Gel P4 column was separated into peak I (1523 tubes), peak II (2430 tubes), and peak III (3134 tubes). 

Phrase: "(A) First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Bio-Gel P10 chromatography,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C0008559:Gel Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "an AD polysaccharide fraction from a Bio-Gel P4 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1264633:Fraction [Quantitative Concept]
   739   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "separated into peak I (1523 tubes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0021966:I- [Inorganic Chemical]
   753   C0086972:Separated [Finding]
   753   C0175730:tubes [Medical Device]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0443299:separated [Spatial Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1547937:Tubes [Intellectual Product]
   753   C1704474:Tubes [Quantitative Concept]
   719 E C1561954:tube [Conceptual Entity]
   719 E C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "peak II"

Phrase: "(2430 tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "peak III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "(3134 tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: ")."
Processing 00000000.tx.67: (B) Second, using Bio-Gel P60 chromatography, peak I (1523 tubes) was further separated into peak Ia (1014 tubes) and peak Ib (1520 tubes). 

Phrase: "(B) Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0205436:Second [Quantitative Concept]
   861   C0457385:Second [Temporal Concept]
   861   C0565930:/second [Quantitative Concept]
   861   C1561503:second [Idea or Concept]
   861   C1705190:Second [Qualitative Concept]
   789 E C0027627:secondary [Neoplastic Process]
   789 E C0175668:Secondary [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Bio-Gel P60 chromatography,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C0008559:Gel Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "peak I (1523 tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0175730:tubes [Medical Device]
   812   C1547937:Tubes [Intellectual Product]
   812   C1704474:Tubes [Quantitative Concept]
   779 E C1561954:tube [Conceptual Entity]
   779 E C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "separated into peak Ia (1014 tubes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0086972:Separated [Finding]
   753   C0175730:tubes [Medical Device]
   753   C0443299:separated [Spatial Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1547937:Tubes [Intellectual Product]
   753   C1704474:Tubes [Quantitative Concept]
   753   C1947960:Ia [Mammal]
   719 E C1561954:tube [Conceptual Entity]
   719 E C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "peak Ib (1520 tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0175730:tubes [Medical Device]
   812   C1547937:Tubes [Intellectual Product]
   812   C1704474:Tubes [Quantitative Concept]
   779 E C1561954:tube [Conceptual Entity]
   779 E C1704730:TUBE [Medical Device]

Phrase: ")."
Processing 00000000.tx.68: Flow rate: 0.2 ml/min, 1.6 ml/tube.  

Phrase: "Flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: ":"

Phrase: "0.2 ml/min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439445:mL/min [Quantitative Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "1.6 ml/tube."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175730:Tube [Medical Device]
   812   C1547937:Tube NOS [Intellectual Product]
   812   C1561954:tube [Conceptual Entity]
   812   C1704730:TUBE [Medical Device]
Processing 00000000.tx.69: To separate peak I more fully from peaks II and III, it was further size-fractionated by Bio-Gel P60 chromatography (Figure 3B). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "peak I more fully from peaks II"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0444505:Peak [Quantitative Concept]
           peaks

Phrase: "and"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "further size-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "fractionated by Bio-Gel P60 chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0008559:Gel Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]
   753   C1979893:Fractionated [Qualitative Concept]
   753   C3539537:p60 [Gene or Genome]
   753   C3540648:p60 [Amino Acid, Peptide, or Protein]

Phrase: "(Figure 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.70: This yielded two peaks. 

Phrase: "This yielded two peaks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]
Processing 00000000.tx.71: Examining each peak by 1D 1H NMR spectroscopy demonstrated that the 5.4 ppm resonance was obtained only from peak Ia (tubes 1014) (Figure 4A). 

Phrase: "Examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "each peak by 1D 1H NMR spectroscopy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0444505:Peak [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the 5.4 ppm resonance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0231881:Resonance [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "only from peak Ia (tubes 1014"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0175730:tubes [Medical Device]
   753   C0205171:Only [Quantitative Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C1547937:Tubes [Intellectual Product]
   753   C1704474:Tubes [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1947960:Ia [Mammal]
   719 E C1561954:tube [Conceptual Entity]
   719 E C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: "(Figure 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.72: The peak Ia spectrum lacked the other anomeric protons with different resonances seen in Figure 2A. 

Phrase: "The peak Ia spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "the other anomeric protons with different resonances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033727:Protons [Element, Ion, or Isotope]

Phrase: "seen in Figure 2A."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.73: Peak Ia contains 5% of the neutral polysaccharides purified from the AD brains or 50 g/g wet-weight brain tissue. 

Phrase: "Peak Ia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "5% of the neutral polysaccharides"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   760   C0439084:>5 [Quantitative Concept]
   760   C0728893:+5 [Quantitative Concept]
   760   C1882074:Neutral [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]
   726 E C2348281:Polysaccharide [Carbohydrate]

Phrase: "purified from the AD brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C1998793:Purified [Functional Concept]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "50 g/g wet-weight brain tissue."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   829   C0006114:wet brain [Pathologic Function]
   829   C1527311:wet brain [Disease or Syndrome]
   818   C0440746:Brain tissue [Tissue]
   818   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   795   C0006104:Brain [Body Part, Organ, or Organ Component]
   795   C0040300:Tissue [Tissue]
   795   C1269537:Brain [Body Part, Organ, or Organ Component]
   795   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.74: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.75: 4. 

Phrase: "4."
Processing 00000000.tx.76: 500 MHz 1D 1H NMR spectrum of peak Ia polysaccharides from an AD brain and a commercially obtained amylose sample. 

Phrase: "500 MHz 1D 1H NMR spectrum of peak Ia polysaccharides"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   770   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   770   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   753   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   753   C1551403:Magnetic resonance [Laboratory Procedure]
   736   C0024488:Magnetic [Occupation or Discipline]
   736   C0231881:Resonance [Finding]
   736   C0459800:resonance [Natural Phenomenon or Process]
   736   C0521447:Nuclear [Spatial Concept]
   736   C0563532:magnetic [Natural Phenomenon or Process]
   736   C0684213:Resonance [Qualitative Concept]
   736   C1883073:Spectrum [Quantitative Concept]
   736   C2827424:Spectrum [Conceptual Entity]

Phrase: "from an AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a commercially obtained amylose sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0370003:Sample [Substance]
   812   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.77: (A) The single resonance in the anomeric proton region is at 5.4 ppm. 

Phrase: "(A)"

Phrase: "The single resonance in the anomeric proton region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0231881:Resonance [Finding]
   744   C0459800:resonance [Natural Phenomenon or Process]
   744   C0684213:Resonance [Qualitative Concept]

Phrase: "is at 5.4 ppm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439187:ppm [Quantitative Concept]
Processing 00000000.tx.78: The resonance at 2.0 ppm indicates that a trace amount of N-acetyl group is present. 

Phrase: "The resonance at 2.0 ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439187:ppm [Quantitative Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "a trace amount of N-acetyl group"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0442822:trace amount [Quantitative Concept]
   748   C1265611:Amount [Quantitative Concept]

Phrase: "is"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.79: (B) The authentic amylose sample shows the same 5.4 ppm proton resonance. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The authentic amylose sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the same 5.4 ppm proton resonance."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0231881:Resonance [Finding]
   799   C0459800:resonance [Natural Phenomenon or Process]
   799   C0684213:Resonance [Qualitative Concept]
   727 E C0577554:Resonant [Qualitative Concept]
Processing 00000000.tx.80: The arrow indicates the water peak. 

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the water peak."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]
Processing 00000000.tx.81: The spectra were recorded in D2O solution at 50C. 

Phrase: "The spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded in D2O solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]
   737   C0034869:Record [Intellectual Product]

Phrase: "at 50C."
Processing 00000000.tx.82: Chemical shifts were expressed in ppm from acetone (2.225 ppm).  

Phrase: "Chemical shifts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220806:Chemical [Chemical]
   861   C0333051:shifts [Functional Concept]
   861   C3272558:Chemical [Intellectual Product]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "expressed in ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439187:ppm [Quantitative Concept]

Phrase: "from acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: "(2.225 ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439187:ppm [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.83: The polysaccharides in peak Ia are composed exclusively of glucose, as verified by GC. 

Phrase: "The polysaccharides in peak Ia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   726 E C2348281:Polysaccharide [Carbohydrate]

Phrase: "are"

Phrase: "composed"

Phrase: "exclusively of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "verified by GC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008555:Gas Chromatography [Laboratory Procedure]
   770   C0008550:Chromatography [Laboratory Procedure]
   770   C0017110:Gas [Chemical Viewed Structurally]
   770   C0596601:Gas [Sign or Symptom]
   770   C1711411:Verified [Functional Concept]
Processing 00000000.tx.84: The 5.4 ppm chemical shift of the anomeric proton, together with a coupling constant of less than 4, indicates an linkage. 

Phrase: "The 5.4 ppm chemical shift of the anomeric proton,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0220806:Chemical [Chemical]
   739   C0333051:Shift [Functional Concept]
   739   C2347509:Shift [Phenomenon or Process]
   739   C3272558:Chemical [Intellectual Product]

Phrase: "together with a coupling constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]

Phrase: "of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than 4,"

Phrase: "indicates"

Phrase: "an linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]
Processing 00000000.tx.85: A spectrum of an authentic sample of amylose was acquired under the same conditions (Figure 4B) and was identical to the one obtained on the putative amylose sample from AD brain (Figure 4A). 

Phrase: "A spectrum of an authentic sample of amylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1883073:Spectrum [Quantitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]

Phrase: "was"

Phrase: "acquired under the same conditions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0439661:Acquired [Temporal Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C3245488:acquired [Intellectual Product]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   726 E C1706701:Acquire [Activity]

Phrase: "(Figure 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "identical to the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]

Phrase: "obtained on the putative amylose sample"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C1277697:Sample obtained [Finding]
   753   C0002732:Amylose [Carbohydrate]
   753   C0370003:Sample [Substance]
   753   C1301820:Obtained [Functional Concept]
   753   C2347026:Sample [Conceptual Entity]
   719 E C1706701:Obtain [Activity]

Phrase: "from AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Figure 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.86: The linkage of the glucose polymers was further investigated using methylation analysis (Figure 5). 

Phrase: "The linkage of the glucose polymers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "methylation analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(Figure 5"

Phrase: ")."
Processing 00000000.tx.87: GC of the methylated alditol acetates showed one predominant peak and two trace peaks. 

Phrase: "GC of the methylated alditol acetates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0008555:Gas Chromatography [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0017110:Gas [Chemical Viewed Structurally]
   748   C0596601:Gas [Sign or Symptom]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "one predominant peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:Peak [Quantitative Concept]

Phrase: "and"

Phrase: "two trace peaks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]
Processing 00000000.tx.88: The GCmass spectrometry (MS) spectrum of the predominant peak shows a fragment 2,3,6-Me3-Glc, demonstrating that the linkage was 1,4-linkage. 

Phrase: "The GCmass spectrometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0436196:Spectrometry [Laboratory Procedure]

Phrase: "(MS) spectrum of the predominant peak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883073:Spectrum [Quantitative Concept]
   753   C2827424:Spectrum [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a fragment 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-Me3-Glc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008556:GLC [Laboratory Procedure]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "was"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023745:linkage [Molecular Function]
Processing 00000000.tx.89: Some minor peaks corresponding to undermethylated products were also observed. 

Phrase: "Some minor peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "corresponding to undermethylated products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1514468:Products [Entity]
   737 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.90: There were no peaks corresponding to 1,6-branching or terminal residues (nonreducing residues). 

Phrase: "There"

Phrase: "were"

Phrase: "no peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "corresponding to 1,"

Phrase: "6-branching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205384:Branching [Spatial Concept]

Phrase: "or"

Phrase: "terminal residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(nonreducing residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.91: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.93: Linkage analysis, using GC-MS, of the glucose polymer purified from an AD brain. 

Phrase: "Linkage analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0796345:linkage analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0023745:linkage [Molecular Function]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GC-MS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]
   734   C0008555:Gas Chromatography [Laboratory Procedure]

Phrase: "of the glucose polymer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   761 E C1218520:Polymeria [Plant]

Phrase: "purified from an AD brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1998793:Purified [Functional Concept]
Processing 00000000.tx.94: Partially methylated alditol acetate of polysaccharides from peak Ia were analyzed by GC-MS. 

Phrase: "Partially methylated alditol acetate of polysaccharides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "from peak Ia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "were"

Phrase: "analyzed by GC-MS."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0008555:Gas Chromatography [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0017110:Gas [Chemical Viewed Structurally]
   760   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0596601:Gas [Sign or Symptom]
   760   C0936012:Analyzed [Research Activity]
   760   C2349943:Ms. [Conceptual Entity]
   760   C3539704:MS [Gene or Genome]
Processing 00000000.tx.95: Analyzing the major peak from the GC spectrum by GC-MS showed 1,4,5-Tri-O-acetyl-2,3,6-Tri-O-methyl glucose. 

Phrase: "Analyzing"

Phrase: "the major peak from the GC spectrum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0444505:Peak [Quantitative Concept]

Phrase: "by GC-MS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]
   734   C0008555:Gas Chromatography [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "5-Tri-O-acetyl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0814229:TRI [Intellectual Product]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-Tri-O-methyl glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.96: This result indicates an 1,4-linkage for the glucose polymer.  

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "indicates"

Phrase: "an 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-linkage for the glucose polymer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]
Processing 00000000.tx.97: To determine the molecular weight of amylose purified from AD brains, peak Ia was further fractionated using Sepharose 4B sizing chromatograpy (Figure 6). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the molecular weight of amylose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0026385:Molecular Weight [Quantitative Concept]
   760   C0005910:weight [Organism Attribute]
   760   C0043100:Weight [Quantitative Concept]
   760   C1305866:weight [Diagnostic Procedure]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1705104:Weight [Idea or Concept]

Phrase: "purified from AD brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "peak Ia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sepharose 4B sizing chromatograpy"

Phrase: "(Figure 6"

Phrase: ")."
Processing 00000000.tx.98: Two separate fractions were obtained. 

Phrase: "Two separate fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.99: The molecular weight of fraction I was over 1,000,000 Da. 

Phrase: "The molecular weight of fraction I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]

Phrase: "was"

Phrase: "over 1,000,000 Da."
Processing 00000000.tx.100: The molecular weight of fraction II was about 600,000 Da. 

Phrase: "The molecular weight of fraction II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]

Phrase: "was"

Phrase: "about 600,000 Da."
Processing 00000000.tx.101: At the lower molecular weight limit, only 0.027% of the linkages should be terminal. 

Phrase: "At the lower molecular weight limit,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0439801:limit [Functional Concept]
   812   C1549649:Limit [Idea or Concept]
   812   C2349209:Limit [Conceptual Entity]
   741 E C3542948:Limited [Intellectual Product]

Phrase: "only 0.027% of the linkages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205171:Only [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]
   719   C0023745:linkage [Molecular Function]

Phrase: "should"

Phrase: "be"

Phrase: "terminal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205088:Terminal [Temporal Concept]
  1000   C1705314:Terminal [Manufactured Object]
  1000   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.102: This is consistent with no signal being observed for terminal residues in the methylation analysis. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with no signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "being"

Phrase: "observed for terminal residues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205088:Terminal [Temporal Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1705314:Terminal [Manufactured Object]
   770   C1705315:Terminal [Spatial Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in the methylation analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.103: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.104: 6. 

Phrase: "6."
Processing 00000000.tx.105: Molecular weights of amylose in an AD brain. 

Phrase: "Molecular weights of amylose"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0026385:Molecular weights [Quantitative Concept]
   770   C0043100:Weights [Quantitative Concept]
   770   C1521991:Molecular [Qualitative Concept]
   737 E C0005910:weight [Organism Attribute]
   737 E C1305866:weight [Diagnostic Procedure]
   737 E C1705104:Weight [Idea or Concept]

Phrase: "in an AD brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.106: Peak Ia purified from an AD brain was fractionated on a Sepharose 4B column (44 x 1 cm) using Dextran 1,111,000 Da, 411,000 Da, 273,000 Da, 80,000 Da, and 48,600 Da as standards. 

Phrase: "Peak Ia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "purified from an AD brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1998793:Purified [Functional Concept]

Phrase: "was"

Phrase: "fractionated on a Sepharose 4B column"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   753   C0036681:Sepharose [Carbohydrate]
   753   C0450375:4b [Intellectual Product]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1979893:Fractionated [Qualitative Concept]

Phrase: "(44 x 1 cm)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Dextran 1,111,000 Da,"

Phrase: "411,000 Da,"

Phrase: "273,000 Da,"

Phrase: "80,000 Da,"

Phrase: "and"

Phrase: "48,600 Da as standards."
Processing 00000000.tx.107: The molecular weight of fraction I in the exclusion volume is over 1,000,000 Da. 

Phrase: "The molecular weight of fraction I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]

Phrase: "in the exclusion volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "is"

Phrase: "over 1,000,000 Da."
Processing 00000000.tx.108: The molecular weight of fraction II is about 600,000 Da. 

Phrase: "The molecular weight of fraction II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]

Phrase: "is"

Phrase: "about 600,000 Da."
Processing 00000000.tx.109: Flow rate 0.2 ml/min, 1.6 ml/tube.  

Phrase: "Flow rate 0.2 ml/min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439445:mL/min [Quantitative Concept]
   799   C0702093:/min [Temporal Concept]

Phrase: "1.6 ml/tube."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175730:Tube [Medical Device]
   812   C1547937:Tube NOS [Intellectual Product]
   812   C1561954:tube [Conceptual Entity]
   812   C1704730:TUBE [Medical Device]
Processing 00000000.tx.110: We attempted to analyze the tissue distribution of the high-molecular-weight amylose we had purified in biochemical experiments. 

Phrase: "We"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the tissue distribution of the high-molecular-weight amylose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C0945060:Weight of Tissue [Clinical Attribute]
   764   C0040287:Tissue Distribution [Quantitative Concept]
   764   C0220927:tissue distribution [Functional Concept]
   742   C0040300:Tissue [Tissue]
   742   C0520511:distribution [Idea or Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1704711:Distribution [Functional Concept]

Phrase: "we"

Phrase: "had"

Phrase: "purified in biochemical experiments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205474:Biochemical [Functional Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1998793:Purified [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.111: Paraffin sections of AD cortex were treated with potassium iodide/iodine followed by a rinse in sulfuric acid. 

Phrase: "Paraffin sections of AD cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "treated with potassium iodide/iodine"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   844   C1099045:IODINE/POTASSIUM IODIDE [Inorganic Chemical,Pharmacologic Substance]
   806   C0032831:Potassium Iodide [Inorganic Chemical,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   797   C0982235:iodine potassium [Inorganic Chemical,Pharmacologic Substance]
   760   C0021966:Iodide [Inorganic Chemical]
           Iodine-
   760   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0032821:Potassium [Element, Ion, or Isotope]
   760   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0885449:iodine [Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   760   C2348268:Iodine [Element, Ion, or Isotope]
   751 E C1551488:Pima [Population Group]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "followed by a rinse"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C1701810:Rinse [Functional Concept]
   770   C1882955:Rinse [Activity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "in sulfuric acid."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0038784:Sulfuric acid [Inorganic Chemical,Pharmacologic Substance]
  1000   C1161333:sulphuric acid [Pharmacologic Substance]
   964 E C0038775:sulfur acid [Chemical Viewed Structurally]
   950 E C0038787:Sulfurous acid [Inorganic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
   789   C0038774:Sulfur [Element, Ion, or Isotope,Pharmacologic Substance]
   789   C2348286:SULFUR [Element, Ion, or Isotope]
Processing 00000000.tx.112: As expected, corpora amylacea (not shown) stained bright purple (as reviewed in Cavanagh, 1999). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "corpora amylacea"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333564:Corpora amylacea [Pathologic Function]
  1000   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   827   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "bright purple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439542:Purple [Qualitative Concept]

Phrase: "("

Phrase: "as"

Phrase: "reviewed in Cavanagh,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.113: In addition, senile plaques were lightly stained above background (Figure 7A, arrows). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "were"

Phrase: "lightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881376:Lightly [Qualitative Concept]

Phrase: "stained above background"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0805222:Background stain [Indicator, Reagent, or Diagnostic Aid]
   790   C1706907:Background [Conceptual Entity]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Figure 7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.114: At higher magnification, plaques exhibited weak gray-purplish staining (Figure 7B). 

Phrase: "At higher magnification,"

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "weak gray-purplish staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "(Figure 7B"

Phrase: ")."
Processing 00000000.tx.115: The light labeling of senile plaques using a stain for starch had not previously been reported. 

Phrase: "The light labeling of senile plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a stain for starch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "had"

Phrase: "not previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.116: View larger version (93K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(93K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 7. 

Phrase: "7."
Processing 00000000.tx.118: Senile plaques in an AD brain. 

Phrase: "Senile plaques in an AD brain."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   753   C0392079:Senile [Finding]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]
Processing 00000000.tx.119: Paraffin-sectioned AD cortex was treated with a stain for starch. 

Phrase: "Paraffin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030415:Paraffin [Biomedical or Dental Material,Lipid]

Phrase: "sectioned"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "AD cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "was"

Phrase: "treated with a stain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for starch."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038179:Starch [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.120: (A) Low-power magnification shows five weakly stained senile plaques (arrows). 

Phrase: "(A) Low-power magnification"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "five weakly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205451:Five [Quantitative Concept]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.121: Bar, 100 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.122: (B) High-power magnification shows a dense deposit within a senile plaque that stained weakly grayish purple. 

Phrase: "(B) High-power magnification"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a dense deposit within a senile plaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333562:Deposit [Functional Concept]

Phrase: "that"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "weakly grayish purple."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439542:Purple [Qualitative Concept]
Processing 00000000.tx.123: Bar, 10 m.   

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.124: Discussion Top Abstract Introduction Results Discussion Materials and methods References  Glucose polymers in the form of glycogen are known to be present in a variety of tissues. 

Phrase: "Discussion Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glucose polymers in the form of glycogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0017696:glucose polymers [Carbohydrate,Pharmacologic Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in a variety of tissues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.125: However, the presence of unbranched glucose polymers had not previously been determined by structural analysis. 

Phrase: "However,"

Phrase: "the presence of unbranched glucose polymers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "not previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined by structural analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0204514:Structural analysis [Therapeutic or Preventive Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0678594:Structural [Spatial Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.126: Here we reported that the cerebral cortex of AD brains contains amylose, an unbranched glucose polymer. 

Phrase: "Here"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the cerebral cortex of AD brains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2700441:Cortex [Plant]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "amylose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "an unbranched glucose polymer."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   727 E C1218520:Polymeria [Plant]
Processing 00000000.tx.127: Glycogen is branched (1,6) every 812 residues and therefore methylation analysis should yield 812% terminal (2,3,4,6-methylated) and branching (2,3-methylated) residues. 

Phrase: "Glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "is"

Phrase: "branched"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1253959:branched [Body Part, Organ, or Organ Component]
  1000   C2700384:Branched [Spatial Concept]
   966 E C1881507:Branch [Chemical Viewed Structurally]
   966 E C2700383:Branch [Plant]
   966 E C2826234:BRANCH [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "6"

Phrase: ")"

Phrase: "every 812 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "therefore methylation analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "should"

Phrase: "yield"

Phrase: "812% terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "6-methylated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0746574:methylated [Pharmacologic Substance]
   789 E C0025723:Methylation [Molecular Function]
   789 E C1159269:Methylation [Molecular Function]

Phrase: ")"

Phrase: "and"

Phrase: "branching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205384:Branching [Spatial Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-methylated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0746574:methylated [Pharmacologic Substance]
   789 E C0025723:Methylation [Molecular Function]
   789 E C1159269:Methylation [Molecular Function]

Phrase: ")"

Phrase: "residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.128: The glucose polymers we isolated from AD brains did not show evidence for 1,6-branching, indicating that these polymers were not a form of high-molecular-weight glycogen. 

Phrase: "The glucose polymers"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0017696:glucose polymers [Carbohydrate,Pharmacologic Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   755 E C1218520:Polymeria [Plant]

Phrase: "we"

Phrase: "isolated from AD brains"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "evidence for 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "6-branching,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205384:Branching [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "these polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a form of high-molecular-weight glycogen."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
Processing 00000000.tx.129: Amylose, unlike glycogen, does not serve as an accessible energy storage in the brain because it is only efficiently broken down by amylase, an enzyme present in the digestive tract. 

Phrase: "Amylose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "unlike glycogen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "serve as an accessible energy storage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0337174:Storage [Spatial Concept]
   753   C0424589:Energy [Finding]
   753   C0542479:Energy [Natural Phenomenon or Process]
   753   C1442080:Energy [Quantitative Concept]
   753   C1698986:Storage [Functional Concept]
   753   C1753314:storage [Cell Component]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "only efficiently broken down by amylase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0443161:break down [Qualitative Concept]
   719   C1881704:BREAK [Phenomenon or Process]

Phrase: "an enzyme present in the digestive tract."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
Processing 00000000.tx.130: Therefore the pathological synthesis of amylose may contribute to the impaired glucose metabolism documented in AD brains. 

Phrase: "Therefore"

Phrase: "the pathological synthesis of amylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "may"

Phrase: "contribute to the impaired glucose metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0596620:glucose metabolism [Molecular Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0221099:Impaired [Functional Concept]
   753   C0684336:Impaired [Pathologic Function]
   753   C1880177:Contribute [Activity]

Phrase: "documented in AD brains."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.131: Although the brain depends on glucose uptake from the blood, brain glycogen is increasingly implicated in normal brain function and protective responses as a result of brain injury. 

Phrase: "Although"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "depends on glucose uptake"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1159527:glucose uptake [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]
   770   C0725813:depend [Medical Device]

Phrase: "from the blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "brain glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "is"

Phrase: "increasingly"

Phrase: "implicated in normal brain function"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0678908:brain function [Organ or Tissue Function]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0031843:function [Physiologic Function]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1705273:Function [Intellectual Product]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "protective responses as a result of brain injury."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]
Processing 00000000.tx.132: Glycogen stores in the brain have been historically underestimated to be only 23 mol/g because brain glycogen is rapidly metabolized and thus disappears within minutes postmortem. 

Phrase: "Glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "stores in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1698986:Store [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "historically"

Phrase: "underestimated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "only 23 mol/g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2347285:mol/g [Quantitative Concept]
   812   C0439267:g% [Quantitative Concept]

Phrase: "because"

Phrase: "brain glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "metabolized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524026:Metabolized [Cell Function]

Phrase: "and"

Phrase: "thus"

Phrase: "disappears within minutes postmortem."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0004398:postmortem [Diagnostic Procedure]
   770   C0439232:minute [Temporal Concept]
   770   C0580205:Postmortem [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C0848632:post mortem [Finding]
   770   C1282918:Minute [Quantitative Concept]
   770   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.133: However, Cruz and Dienel (2003) estimated that the concentration of glycogen is as much as 812 mol/g by measuring glucose in ethanol-insoluble brain fractions after handling of animals with minimal environmental stimuli. 

Phrase: "However,"

Phrase: "Cruz"

Phrase: "and"

Phrase: "Dienel"

Phrase: "(2003"

Phrase: ")"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "that"

Phrase: "the concentration of glycogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "as"

Phrase: "much as 812 mol/g"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C2347285:mol/g [Quantitative Concept]
   797 E C2348885:g/mol [Quantitative Concept]
   760   C0027960:Mole [Neoplastic Process]
   760   C0324740:Mole [Mammal]
   760   C0439189:Mole [Quantitative Concept]
   760   C0439267:g% [Quantitative Concept]
   760   C1456781:mole [Neoplastic Process]
   760   C1824986:mol [Gene or Genome]

Phrase: "by measuring glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in ethanol-insoluble brain fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "after handling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018578:Handling [Behavior]
  1000   C1832073:Handling [Finding]

Phrase: "of animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "with minimal environmental stimuli."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0450025:Environmental stimuli [Natural Phenomenon or Process]
   827   C0234402:Stimuli [Phenomenon or Process]
Processing 00000000.tx.134: If amylose is synthesized at the expense of glycogen, one would expect an impaired glucose metabolism. 

Phrase: "If"

Phrase: "amylose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "is"

Phrase: "synthesized at the expense of glycogen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0680864:expense [Quantitative Concept]
   753   C1883254:Synthesized [Activity]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "would"

Phrase: "expect"

Phrase: "an impaired glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.135: The concentration of amylose that we purified from AD brains is 50 g (0.3 mol)/g wet weight of brain, which is only 310% of the glycogen concentration estimated for rat brain. 

Phrase: "The concentration of amylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "purified from AD brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "50 g (0.3 mol"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   875   C2348885:g/mol [Quantitative Concept]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ")"

Phrase: "/g wet weight of brain,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0006114:brain wet [Pathologic Function]
   797   C0870228:brain weight [Quantitative Concept]
   797   C1527311:wet brain [Disease or Syndrome]
   760   C0005910:weight [Organism Attribute]
   760   C0043100:Weight [Quantitative Concept]
   760   C0205381:Wet [Qualitative Concept]
   760   C1305866:weight [Diagnostic Procedure]
   760   C1705104:Weight [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "only 310% of the glycogen concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0086045:Concentration [Mental Process]
   753   C0205171:Only [Quantitative Concept]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "estimated for rat brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0750572:Estimated [Quantitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.136: However, if amylose were largely synthesized in particular brain regions, such as the AD-vulnerable regions displaying plaques and tangles, then the local concentration of amylose would be significantly higher. 

Phrase: "However,"

Phrase: "if"

Phrase: "amylose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "were"

Phrase: "largely"

Phrase: "synthesized in particular brain regions,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1273723:brain regions [Body Location or Region]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1883254:Synthesized [Activity]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "such as the AD-vulnerable regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "tangles,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the local concentration of amylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "significantly higher."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]
Processing 00000000.tx.137: Glycogen levels are dynamically regulated during normal brain activity. 

Phrase: "Glycogen levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "dynamically"

Phrase: "regulated during normal brain activity."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0443158:Brain activity [Physiologic Function]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0205177:Activity [Functional Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1561536:*Activity [Idea or Concept]
   760   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.138: The turnover rate varies with synaptic stimulation (Swanson et al., 1992) and sleep deprivation (Kong et al., 2002) and is regulated by neurotransmitters, such as noradrenaline, and vasoactive intestinal peptide (Pellerin et al., 1997). 

Phrase: "The turnover rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "varies with synaptic stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1548673:Varies [Intellectual Product]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Swanson et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: "and"

Phrase: "sleep deprivation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0037316:Sleep Deprivation [Finding]
   861   C0037313:Sleep [Organism Function]
   861   C0871712:Deprivation [Qualitative Concept]
   789 E C0013144:Sleepy [Finding]
   761 E C2830004:SLEEPINESS [Finding]

Phrase: "(Kong et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "regulated by neurotransmitters,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "such as noradrenaline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028351:Noradrenalin [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vasoactive intestinal peptide"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0042395:Vasoactive Intestinal Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1366646:VASOACTIVE INTESTINAL PEPTIDE [Gene or Genome]
   827   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1980011:Vasoactive [Qualitative Concept]
   755 E C1708548:INTESTINE [Tissue]

Phrase: "(Pellerin et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.139: Though glycogen granules are found in dendrites and synaptic terminals of neurons (Peters et al., 1970), astrocytes are generally thought to store most of the brain glycogen used as glucose source, especially during transient increases in metabolic demand (Magistretti and Pellerin, 1999). 

Phrase: "Though"

Phrase: "glycogen granules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1325641:glycogen granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "are"

Phrase: "found in dendrites"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0011305:Dendrites [Cell Component]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "synaptic terminals of neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0206181:Synaptic Terminals [Cell Component]
   737   C0205088:Terminal [Temporal Concept]
   737   C1705314:Terminal [Manufactured Object]
   737   C1705315:Terminal [Spatial Concept]

Phrase: "(Peters et al.,"

Phrase: "1970"

Phrase: ")"

Phrase: ","

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "are"

Phrase: "generally"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "store"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1698986:Store [Functional Concept]

Phrase: "most of the brain glycogen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   760   C0205393:Most [Quantitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "used as glucose source,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0449416:Source [Finding]
   770   C1273517:used [Finding]
   770   C1705919:Source [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "especially during transient increases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040704:Transient [Population Group]
   770   C0205374:Transient [Temporal Concept]
   770   C0442805:increases [Functional Concept]

Phrase: "in metabolic demand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441516:Demand [Therapeutic or Preventive Procedure]
   861   C0699784:demand [Idea or Concept]

Phrase: "(Magistretti"

Phrase: "and"

Phrase: "Pellerin,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.140: During brain injury, for example, due to ischemia or epileptic activity, there is a dramatic increase in astrocytic glycogen (Swanson et al., 1989). 

Phrase: "During brain injury,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0270611:Brain Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "due to ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "or"

Phrase: "epileptic activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "there"

Phrase: "is"

Phrase: "a dramatic increase in astrocytic glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(Swanson et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.141: In central white matter, as result of glucose deprivation, astrocytic glycogen is broken down to lactate, which is then transferred to axons for fuel (Choi et al., 2003), similar to the nourishing of neurons through astrocytic lactate, first described for synaptic areas (as reviewed in Meeks and Mennerick, 2003). 

Phrase: "In central white matter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0682708:White matter [Tissue]
   827   C0007457:White [Population Group]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]

Phrase: "as"

Phrase: "result of glucose deprivation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "astrocytic glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "is"

Phrase: "broken down to lactate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0443161:break down [Qualitative Concept]
   737   C1881704:BREAK [Phenomenon or Process]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "which"

Phrase: "is"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred to axons"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0004461:Axons [Cell Component]
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705822:Transfer [Activity]

Phrase: "for fuel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0556991:Fuel [Manufactured Object]

Phrase: "(Choi et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "similar to the nourishing of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "through astrocytic lactate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022924:lactate [Organic Chemical]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "described for synaptic areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205146:areas [Spatial Concept]
   770   C1552738:described [Idea or Concept]
   737 E C0017446:Area [Geographic Area]

Phrase: "("

Phrase: "as"

Phrase: "reviewed in Meeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Mennerick,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.142: Elevation in astrocytic glycogen is found in necrotic lesions resulting from ischemia (Kajihara et al., 2001) and therefore might also be used as an energy source during inflammatory responses. 

Phrase: "Elevation in astrocytic glycogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439775:Elevation [Therapeutic or Preventive Procedure]
   770   C0702240:Elevation [Spatial Concept]

Phrase: "is"

Phrase: "found in necrotic lesions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   816   C1334929:Necrotic Lesion [Finding]
   770   C0027540:Necrotic [Organ or Tissue Function]
   770   C0150312:Found [Quantitative Concept]
   770   C0221198:lesions [Finding]
   737 E C0243095:Find [Finding]
   737 E C1546698:Lesion [Intellectual Product]

Phrase: "resulting from ischemia"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0022116:Ischaemia [Disease or Syndrome]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]
   718 E C0475224:Ischaemic [Functional Concept]

Phrase: "(Kajihara et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "therefore"

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "used as an energy source"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0014275:energy source [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0449416:Source [Finding]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C1273517:used [Finding]
   760   C1442080:Energy [Quantitative Concept]
   760   C1705919:Source [Idea or Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "during inflammatory responses."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1155266:inflammatory responses [Pathologic Function]
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]
Processing 00000000.tx.143: AD brains are noted for their progressive reduction in glucose metabolism and blood flow, more so in association than in primary cortical regions (Hampel et al., 2002) as demonstrated by in vivo imaging of the uptake of the inert radiolabeled glucose analog deoxyglucose. 

Phrase: "AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "noted for their progressive reduction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205329:Progressive [Functional Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "in glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "blood flow,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0232338:Blood flow [Organism Function]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0806140:Flow [Natural Phenomenon or Process]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "more so in association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004083:Association [Mental Process]
   770   C0205172:More [Functional Concept]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "than"

Phrase: "in primary cortical regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(Hampel et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: "as"

Phrase: "demonstrated by in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging of the uptake of the inert radiolabeled glucose analog deoxyglucose."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   756   C0596619:glucose analog [Carbohydrate]
   754   C1159527:glucose uptake [Cell Function]
   738   C0011501:Deoxyglucose [Carbohydrate,Pharmacologic Substance]
   738   C0011923:Imaging [Diagnostic Procedure]
   738   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0079595:Imaging [Diagnostic Procedure]
   738   C0243071:Analog [Chemical Viewed Structurally]
   738   C0243144:Uptake [Physiologic Function]
   738   C0347980:% uptake [Quantitative Concept]
   738   C1527121:Radiolabeled [Qualitative Concept]
   704 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   704 E C1704254:Image [Intellectual Product]
   704 E C1704922:Image [Entity]
   704 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.144: This is compatible with the relative lack of amyloid plaques and neurofibrillary tangles in primary cortical areas. 

Phrase: "This"

Phrase: "is"

Phrase: "compatible with the relative lack of amyloid plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332290:compatible [Idea or Concept]
   744   C1524057:Compatible [Qualitative Concept]

Phrase: "and"

Phrase: "neurofibrillary tangles in primary cortical areas."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.145: One known indicator of impaired glucose metabolism in AD are the decreased levels of glucose transporters (Vanucci et al., 1998). 

Phrase: "One known indicator of impaired glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   748   C1235732:Indicator [Bird]
   748   C1522602:Indicator [Functional Concept]

Phrase: "in AD"

Phrase: "are"

Phrase: "the decreased levels of glucose transporters"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   809   C0017746:Glucose, decreased level [Finding]
   783   C0428548:glucose levels [Laboratory or Test Result]
   767 E C0337438:glucose level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Vanucci et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.146: Glucose uptake is impaired by lipid peroxidation that leads to the covalent modification of glucose transporters with aldehydes such as 4-hydroxynonenal (Mattson, 1998). 

Phrase: "Glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "impaired by lipid peroxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023775:Lipid Peroxidation [Molecular Function]
   770   C0023779:Lipid [Lipid]
   770   C0178796:peroxidation [Phenomenon or Process]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]

Phrase: "that"

Phrase: "leads to the covalent modification of glucose transporters"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0392747:Modification [Functional Concept]
   744   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1511539:Covalent [Molecular Function]
   744   C1522538:Lead [Functional Concept]
   744   C1554963:modification [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with aldehydes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001992:Aldehydes [Organic Chemical]

Phrase: "such as 4-hydroxynonenal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "(Mattson,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.147: Glucose transport is also impaired as vascular endothelial cells are exposed to amyloid- peptide (A) (Blanc et al., 1997), which presumably occurs during cerebral amyloid angiopathy. 

Phrase: "Glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "also"

Phrase: "impaired as vascular endothelial cells"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   862   C1257792:Vascular Endothelial Cells [Cell]
   806   C0225336:Endothelial Cells [Cell]
   770   C0014261:Endothelium, Vascular [Tissue]
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0007634:Cells [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1558950:VASCULAR [Finding]
   760   C1801960:Vascular [Qualitative Concept]
   760   C3282337:Cells [Cell]
   747   C0005773:Blood Cells [Cell]
   743 E C1706972:Blood Vessel Endothelium [Tissue]
   739 E C2328697:Hemal cell [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "are"

Phrase: "exposed to amyloid- peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A) (Blanc et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "which presumably"

Phrase: "occurs during cerebral amyloid angiopathy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0085220:Cerebral Amyloid Angiopathy [Disease or Syndrome]
   806   C2931784:Amyloid angiopathy [Disease or Syndrome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0042373:Angiopathy [Disease or Syndrome]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.148: In contrast, the secreted form of neuroprotective amyloid precursor protein enhances glucose transport and protects against the A effect (Mattson et al., 1999). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the secreted form of neuroprotective amyloid precursor protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "protects against the"

Phrase: "A effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "(Mattson et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.149: The majority of the cerebral glucose uptake/metabolism was thought to be an insulin-independent process (Seaquist et al., 2001) because endothelial cells and astrocytes express the insulin-insensitive glucose transporters GLUT1 and 3. 

Phrase: "The majority of the cerebral glucose uptake/metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0680220:majority [Social Behavior]

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an insulin-independent process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "(Seaquist et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "because"

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "express"

Phrase: "the insulin-insensitive glucose transporters GLUT1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1335837:GLUT1 [Gene or Genome]
   804   C1504631:Glut-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1705603:GLUT1 [Gene or Genome]

Phrase: "and"

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.150: However, recent studies have reaffirmed that brain glycogen metabolism is highly insulin-sensitive (Choi et al., 2003), even though the insulin-sensitive glucose transporters GLUT4 and are only minor constituents in brain. 

Phrase: "However,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reaffirmed"

Phrase: "that brain glycogen metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0596215:brain metabolism [Organ or Tissue Function]
   901   C0599784:glycogen metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "highly insulin-sensitive"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0439822:Highly sensitive [Qualitative Concept]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0332324:Sensitive [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550474:sensitive [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   817   C0920563:Insulin Sensitivity [Pathologic Function]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Choi et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "even"

Phrase: "though"

Phrase: "the insulin-sensitive glucose transporters GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1420175:GLUT4 [Gene or Genome]
   804   C2982484:GLUT4 [Gene or Genome]

Phrase: "and"

Phrase: "are"

Phrase: "only minor constituents in brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0729650:Constituents [Substance]
Processing 00000000.tx.151: Because GLUT4 and 8 are expressed by neurons, the observed insulin resistance in AD (as reviewed in Watson and Craft, 2003) presumably impairs neuronal glucose metabolism. 

Phrase: "Because"

Phrase: "GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "and"

Phrase: "8"

Phrase: "are"

Phrase: "expressed by neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "the observed insulin resistance in AD ("
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "as"

Phrase: "reviewed in Watson"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   790   C3476816:Watson [Quantitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Craft,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870369:craft [Manufactured Object]

Phrase: "2003"

Phrase: ")"

Phrase: "presumably"

Phrase: "impairs"

Phrase: "neuronal glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.152: Insulin abnormalities and insulin resistance are increasingly implicated in the pathophysiology of AD (as reviewed in Watson and Craft, 2003). 

Phrase: "Insulin abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "increasingly"

Phrase: "implicated in the pathophysiology of AD ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031847:pathophysiology [Functional Concept]
   753   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "as"

Phrase: "reviewed in Watson"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   790   C3476816:Watson [Quantitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Craft,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870369:craft [Manufactured Object]

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.153: Patients with AD are hyperinsulinemic and hyperglycemic compared to healthy control individuals (Razay and Wilcock, 1994). 

Phrase: "Patients with AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "hyperinsulinemic"

Phrase: "and"

Phrase: "hyperglycemic"

Phrase: "compared to healthy control individuals"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C2986479:Healthy Control [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "(Razay"

Phrase: "and"

Phrase: "Wilcock,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.154: Cell culture studies suggest that insulin accelerates trafficking of A from the Golgi and trans-Golgi network to the membrane and thus accelerates the release of A into the extracellular fluid (Gasparini et al., 2001). 

Phrase: "Cell culture studies"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   966   C0681854:cell culture study [Research Activity]
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0947630:studies [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "trafficking of A from the Golgi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018042:Golgi [Cell Component]
   753   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "trans-Golgi network to the membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C2245787:trans-Golgi network membrane [Cell Component]
   833   C0887838:trans-Golgi Network [Cell Component]
   790   C1179875:Golgi network [Cell Component]
   753   C1513822:Network [Professional or Occupational Group]
   753   C1705739:Network [Manufactured Object]
   753   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "thus"

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the release of A into the extracellular fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Gasparini et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.155: Furthermore, increased insulin levels may also interfere with the clearing of A because both are proteolyzed by insulin degrading enzyme. 

Phrase: "Furthermore,"

Phrase: "increased insulin levels"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   983   C1295675:Increased insulin level [Finding]
   901   C0020459:increased insulin [Disease or Syndrome]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "also"

Phrase: "interfere with the clearing of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0521102:Interfere [Qualitative Concept]
   753   C1550003:Clearing [Idea or Concept]

Phrase: "because"

Phrase: "both"

Phrase: "are"

Phrase: "proteolyzed by insulin degrading enzyme."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.156: The degradation of A was shown to be competitively inhibited by insulin (Qiu et al., 1998). 

Phrase: "The degradation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "competitively"

Phrase: "inhibited by insulin"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Qiu et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.157: Furthermore, glycolysis is affected in AD brains as demonstrated by the increased specific activities of phosphofructokinase, pyruvate kinase, and lactate dehydrogenase but the decreased activity in glucose-6-P dehydrogenase. 

Phrase: "Furthermore,"

Phrase: "glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017952:Glycolysis [Molecular Function]

Phrase: "is"

Phrase: "affected in AD brains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "demonstrated by the increased specific activities of phosphofructokinase,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   750   C0474395:increased activity [Finding]
   750   C1150452:phosphofructokinase activity [Molecular Function]
   744   C0031651:Phosphofructokinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0162449:PHOSPHOFRUCTOKINASE [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205217:Increased [Quantitative Concept]
   744   C0205369:Specific [Qualitative Concept]
   744   C0441655:Activities [Activity]
   744   C0442805:Increased [Functional Concept]
   744   C1552740:specific [Intellectual Product]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "pyruvate kinase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "lactate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "the decreased activity in glucose-6-P dehydrogenase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   789   C1151275:glucose dehydrogenase activity [Molecular Function]
   789   C1151276:glucose dehydrogenase activity [Molecular Function]
   770   C0086439:Decreased activity [Sign or Symptom]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.158: The increase in glycolytic enzymes has been attributed to astrocytes that are activated by the inflammatory responses found in AD (Bigl et al., 1999). 

Phrase: "The increase in glycolytic enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to astrocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004112:Astrocytes [Cell]
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "activated by the inflammatory responses"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C1155266:inflammatory responses [Pathologic Function]
   760   C0333348:Inflammatory [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "found in AD (Bigl et al.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0150312:Found [Quantitative Concept]
   719 E C0243095:Find [Finding]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.159: In AD brains, astrocytes show an association between glycogen granules and immunogold-labeled A (Kurt et al., 1999). 

Phrase: "In AD brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an association between glycogen granules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "immunogold-"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "A (Kurt et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.160: On the other hand, amylose, the unbranched glucose polymer, is relatively resistant to degradation and therefore easily detectable postmortem. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "amylose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "the unbranched glucose polymer,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   727 E C1218520:Polymeria [Plant]

Phrase: "is"

Phrase: "relatively resistant to degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "therefore easily detectable postmortem."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0004398:postmortem [Diagnostic Procedure]
   812   C0580205:Postmortem [Temporal Concept]
   812   C0848632:post mortem [Finding]
Processing 00000000.tx.161: In type IV glucose storage disease, amylose accumulates instead of glycogen because of the lack of branching enzyme. 

Phrase: "In type IV glucose storage disease,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   897   C0457464:type disease [Intellectual Product]
   840   C0267971:Storage disease [Disease or Syndrome]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0337174:Storage [Spatial Concept]
   804   C1698986:Storage [Functional Concept]
   804   C1753314:storage [Cell Component]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: "amylose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "accumulates instead of glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "because of the lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "of branching enzyme."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0000052:Branching Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205384:Branching [Spatial Concept]
   827 E C1253959:Branch [Body Part, Organ, or Organ Component]
   827 E C1881507:Branch [Chemical Viewed Structurally]
   827 E C2700383:Branch [Plant]
   827 E C2826234:BRANCH [Intellectual Product]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.162: The glucose polymer that accumulates during normal aging in the human brain in corpora amylacea is also considered to be amylose although its chemical structure was not determined. 

Phrase: "The glucose polymer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   761 E C1218520:Polymeria [Plant]

Phrase: "that"

Phrase: "accumulates during normal aging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001811:Ageing [Organism Function]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "in the human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in corpora amylacea"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333564:Corpora amylacea [Pathologic Function]
  1000   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   827   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "also"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "amylose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "although"

Phrase: "its chemical structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0220807:Chemical Structure [Intellectual Product]
   861   C0220806:Chemical [Chemical]
   861   C0678594:Structure [Spatial Concept]
   861   C3272558:Chemical [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "determined."
Processing 00000000.tx.163: Its molecular weight has been reported to be less than 4,000 Da, which is consistent with the purple staining of corpora amylacea with potassium iodide/iodine followed by sulfuric acid (Sakai et al., 1969). 

Phrase: "Its molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026385:Molecular Weight [Quantitative Concept]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1521991:Molecular [Qualitative Concept]
   861   C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less than 4,000 Da,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0439092:Less Than [Intellectual Product]
           less
   760   C0547044:Less [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with the purple staining of corpora amylacea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "with potassium iodide/iodine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0982235:potassium iodine [Inorganic Chemical,Pharmacologic Substance]
   827   C0021966:Iodine- [Inorganic Chemical]
   827   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0885449:iodine [Pharmacologic Substance]
   827   C2348268:Iodine [Element, Ion, or Isotope]
   734   C0032831:Potassium Iodide [Inorganic Chemical,Pharmacologic Substance]

Phrase: "followed by sulfuric acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0038784:Sulfuric acid [Inorganic Chemical,Pharmacologic Substance]
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C1161333:sulphuric acid [Pharmacologic Substance]
   797 E C0038775:sulfur acid [Chemical Viewed Structurally]
   783 E C0038787:Sulfurous acid [Inorganic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(Sakai et al.,"

Phrase: "1969"

Phrase: ")."
Processing 00000000.tx.164: The glucose polymer that we purified from AD brains has significantly higher molecular weights than the glucose polymer found in corpora amylacea. 

Phrase: "The glucose polymer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   761 E C1218520:Polymeria [Plant]

Phrase: "that"

Phrase: "we"

Phrase: "purified from AD brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "significantly higher molecular weights than the glucose polymer"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0026385:Molecular weights [Quantitative Concept]
   767   C1979900:High molecular weight [Qualitative Concept]
   744   C0043100:Weights [Quantitative Concept]
   744   C1521991:Molecular [Qualitative Concept]
   734   C0948775:high weight [Sign or Symptom]
   725 E C0424638:height weights [Organism Attribute]
   711 E C0005910:weight [Organism Attribute]
   711 E C1305866:weight [Diagnostic Procedure]
   711 E C1705104:Weight [Idea or Concept]

Phrase: "found in corpora amylacea."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0333564:Corpora amylacea [Pathologic Function]
   833   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   737   C0227813:Corpus [Body Part, Organ, or Organ Component]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.165: It occurs as two size populations with molecular weights of about 610,000 Da and more than 1,000,000 Da, respectively. 

Phrase: "It"

Phrase: "occurs as two size populations"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0032683:Population Size [Quantitative Concept]
   760   C0032659:Population [Quantitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0456389:size [Spatial Concept]
   760   C1257890:Population [Population Group]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "with molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "of about 610,000 Da"

Phrase: "and"

Phrase: "more than 1,000,000 Da,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205172:More [Functional Concept]

Phrase: "respectively."
Processing 00000000.tx.166: Though the single anomeric proton of the glucose polymer (5.4 ppm) in the NMR spectrum is consistent with an (1,4)-linkage, this linkage is conclusively demonstrated by the predominant fragment 2,3,6-Me3-Glc in the GC spectrum obtained by methylation analysis. 

Phrase: "Though"

Phrase: "the single anomeric proton of the glucose polymer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033727:Proton [Element, Ion, or Isotope]

Phrase: "(5.4 ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439187:ppm [Quantitative Concept]

Phrase: ")"

Phrase: "in the NMR spectrum"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   923   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   923   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   923   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   861   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   861   C1551403:Magnetic resonance [Laboratory Procedure]
   812   C0024488:Magnetic [Occupation or Discipline]
   812   C0231881:Resonance [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0563532:magnetic [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1883073:Spectrum [Quantitative Concept]
   812   C2827424:Spectrum [Conceptual Entity]
   741 E C0024483:Magnet [Manufactured Object]
   741 E C0577554:Resonant [Qualitative Concept]
   741 E C0885556:magnets [Pharmacologic Substance]
   741 E C1706318:Magnet [Manufactured Object]

Phrase: "is"

Phrase: "consistent with an (1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "4"

Phrase: ")-"

Phrase: "linkage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "this linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "is"

Phrase: "conclusively"

Phrase: "demonstrated by the predominant fragment 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-Me3-Glc in the GC spectrum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0008556:GLC [Laboratory Procedure]

Phrase: "obtained by methylation analysis."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0025723:Methylation [Molecular Function]
   770   C0936012:Analysis [Research Activity]
   770   C1159269:Methylation [Molecular Function]
   770   C1301820:Obtained [Functional Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.167: There is no evidence for 1,6-branching indicating that the polymer is not a form of high-molecular-weight glycogen. 

Phrase: "There"

Phrase: "is"

Phrase: "no evidence for 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "6-branching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205384:Branching [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the polymer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   900 E C1218520:Polymeria [Plant]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a form of high-molecular-weight glycogen."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
Processing 00000000.tx.168: Branching at about every 710 glucose units is a characteristic feature of glycogen that separates it from amylose. 

Phrase: "Branching at about"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205384:Branching [Spatial Concept]

Phrase: "every 710 glucose units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "is"

Phrase: "a characteristic feature of glycogen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1521970:Feature [Qualitative Concept]
   760   C1706388:Feature [Conceptual Entity]
   760   C2346469:Feature [Qualitative Concept]
   760   C2348519:Feature [Qualitative Concept]

Phrase: "that"

Phrase: "separates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443299:Separate [Spatial Concept]
  1000   C1881713:SEPARATES [Phenomenon or Process]

Phrase: "it from amylose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002732:Amylose [Carbohydrate]
Processing 00000000.tx.169: Attempts to histochemically visualize the high-molecular-weight amylose that we purified in biochemical experiments only proved moderately successful. 

Phrase: "Attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to histochemically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "the high-molecular-weight amylose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002732:Amylose [Carbohydrate]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "that"

Phrase: "we"

Phrase: "purified in biochemical experiments only"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0205474:Biochemical [Functional Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1720467:Only [Intellectual Product]
   760   C1998793:Purified [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "proved"

Phrase: "moderately successful."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1272703:Successful [Qualitative Concept]
   789 E C0597535:Success [Social Behavior]
Processing 00000000.tx.170: Using a histological stain for starch, senile plaques stained only weakly grayish-purple in contrast to the intense staining of the lower-molecular-weight glucose polymer concentrated in corpora amylacea. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a histological stain for starch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "only weakly grayish-purple in contrast to the intense staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0439542:Purple [Qualitative Concept]

Phrase: "of the lower-molecular-weight glucose polymer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0017696:Glucose Polymer [Carbohydrate,Pharmacologic Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   704 E C1218520:Polymeria [Plant]

Phrase: "concentrated in corpora amylacea."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0333564:Corpora amylacea [Pathologic Function]
   833   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737   C0227813:Corpus [Body Part, Organ, or Organ Component]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]
Processing 00000000.tx.171: This suggests that most of the high-molecular-weight amylose is soluble, and only traces are retained in paraffin-embedded sectioned material. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that most of the high-molecular-weight amylose"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C1979900:High molecular weight [Qualitative Concept]
   770   C0026385:Molecular Weight [Quantitative Concept]
   767   C0948775:high weight [Sign or Symptom]
   744   C0002732:Amylose [Carbohydrate]
   744   C0005910:weight [Organism Attribute]
   744   C0043100:Weight [Quantitative Concept]
   744   C0205250:High [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1705104:Weight [Idea or Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "is"

Phrase: "soluble,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442822:Trace [Quantitative Concept]
  1000   C1524031:Trace [Qualitative Concept]
  1000   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "retained in paraffin-embedded sectioned material."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0085185:embedded paraffin [Laboratory Procedure]
   753   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   753   C0333118:Retained [Functional Concept]
   753   C0520510:Material [Substance]
   753   C1707903:Embedded [Laboratory Procedure]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]
Processing 00000000.tx.172: We undertook to purify amylose from AD brains because the 5.4 ppm resonance in NMR spectra from AD polysaccharides obtained after Bio-Gel P4 size fractionation suggested the presence of amylose. 

Phrase: "We"

Phrase: "undertook"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "amylose from AD brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002732:Amylose [Carbohydrate]

Phrase: "because"

Phrase: "the 5.4 ppm resonance in NMR spectra"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   782   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   782   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   760   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   760   C1551403:Magnetic resonance [Laboratory Procedure]

Phrase: "from AD polysaccharides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   827 E C2348281:Polysaccharide [Carbohydrate]

Phrase: "obtained after Bio-Gel P4 size fractionation"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0016640:fractionation [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0456389:size [Spatial Concept]
   748   C0524811:fractionation [Therapeutic or Preventive Procedure]
   748   C1301820:Obtained [Functional Concept]
   748   C1382104:Gel [Substance]
   748   C1539372:p4 [Gene or Genome]
   748   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   728   C0332509:Increased size [Finding]
   728   C1268652:increase size [Finding]
   714 E C1706701:Obtain [Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of amylose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.173: That high-molecular-weight amylose may also be present in aged control brains, albeit at a lower abundance, is suggested by the presence of unmetabolized glucose in its polysaccharides, as demonstrated by GC spectrometry. 

Phrase: "That high-molecular-weight amylose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002732:Amylose [Carbohydrate]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "present in aged control brains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "albeit at a lower abundance,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   760   C2346714:Abundance [Qualitative Concept]

Phrase: "is"

Phrase: "suggested by the presence of unmetabolized glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   714   C1705535:Suggest [Idea or Concept]

Phrase: "in its polysaccharides,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   966 E C2348281:Polysaccharide [Carbohydrate]

Phrase: "as"

Phrase: "demonstrated by GC spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0008555:Gas Chromatography [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0017110:Gas [Chemical Viewed Structurally]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0596601:Gas [Sign or Symptom]
Processing 00000000.tx.174: If amylose were synthesized in the AD brain at the expense of glycogen, the result would be an impairment of glucose metabolism leading to neural degeneration.  

Phrase: "If"

Phrase: "amylose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002732:Amylose [Carbohydrate]

Phrase: "were"

Phrase: "synthesized in the AD brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1883254:Synthesized [Activity]

Phrase: "at the expense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680864:expense [Quantitative Concept]

Phrase: "of glycogen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "the result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "would"

Phrase: "be"

Phrase: "an impairment of glucose metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0684336:Impairment [Pathologic Function]

Phrase: "leading to neural degeneration."
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   833   C0027746:neural degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0332152:Leading [Temporal Concept]
   770   C0599851:Neural [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1880269:Degeneration [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0027740:Nerve [Tissue]
   715 E C0027757:NERVE [Tissue]
   715 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.175: Materials and methods Top Abstract Introduction Results Discussion Materials and methods References  Materials Brain tissue was obtained from the Maryland Brain Bank at autopsy from three subjects with advanced AD (91 g, 23 g, 18 g; 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials Brain tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0457457:materials tissue [Tissue]
   901   C0440746:Brain tissue [Tissue]
   901   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissue [Tissue]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "obtained from the Maryland Brain Bank"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0024858:Maryland [Geographic Area]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "at autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "from three subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "with advanced AD (91 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "23 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "18 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.176: 7983 years; 

Phrase: "7983 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.177: postmortem interval: 69 h) and three nondemented, age-matched control subjects (113 g, 40 g, 25 g; 

Phrase: "postmortem interval"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: ":"

Phrase: "69 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "three nondemented, age-matched control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]

Phrase: "(113 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "40 g,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1955160:40 g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "25 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.178: 6790 years; 

Phrase: "6790 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.179: postmortem interval: 4.515 h). 

Phrase: "postmortem interval"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: ":"

Phrase: "4.515 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.180: Bio-Gel P4, P10, and P60 separation media were purchased from Bio-Rad (Hercules, CA). 

Phrase: "Bio-Gel P4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1539372:p4 [Gene or Genome]

Phrase: "P10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0966870:p10 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1425194:p10 [Gene or Genome]
  1000   C1548702:P10 [Intellectual Product]

Phrase: "and"

Phrase: "P60 separation media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Bio-Rad (Hercules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0869011:purchased [Activity]

Phrase: "CA)."
Processing 00000000.tx.181: Hydrazine, anhydrous, p-amino benzoic acid ethyl ester (ABEE), sodium cyanoborate, were purchased from Sigma (St. Louis, MO). 

Phrase: "Hydrazine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020231:Hydrazine [Inorganic Chemical]
  1000   C0020233:Hydrazine [Organic Chemical]

Phrase: "anhydrous,"

Phrase: "p-amino benzoic acid ethyl ester (ABEE),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0014898:Ester [Organic Chemical]

Phrase: "sodium cyanoborate,"

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.182: Delipidation of human brain tissue As a first purification step, the human cortex was delipidated. 

Phrase: "Delipidation of human brain tissue"

Phrase: "As a first purification step,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1722730:First Step [Biomedical or Dental Material]
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "the human cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "was"

Phrase: "delipidated."
Processing 00000000.tx.183: After excision, the brain tissue was frozen and lyophilized. 

Phrase: "After excision,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:excision [Therapeutic or Preventive Procedure]
  1000   C0728940:Excision [Therapeutic or Preventive Procedure]

Phrase: "the brain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "lyophilized."
Processing 00000000.tx.184: After pulverization, each gram of tissue was extracted with 40 ml of a chloroform-methanol-water mixture (4:8:3 by volume). 

Phrase: "After pulverization,"

Phrase: "each gram of tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439208:gram [Quantitative Concept]

Phrase: "was"

Phrase: "extracted with 40 ml of a chloroform-methanol-water mixture"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   777   C2698229:mL of Water [Quantitative Concept]
   739   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   739   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   739   C0185115:Extracted [Therapeutic or Preventive Procedure]
   739   C0439509:/40 [Temporal Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C0439962:Mixture [Substance]
   739   C0599638:WATER [Substance]
   739   C1550678:Water [Inorganic Chemical]
   739   C3541890:EXTRACTED [Finding]
   706 E C2828366:Extract [Substance]

Phrase: "(4"

Phrase: ":"

Phrase: "8"

Phrase: ":"

Phrase: "3 by volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0439086:<3 [Quantitative Concept]
   790   C0449468:*Volume [Quantitative Concept]
   790   C1690016:% volume [Qualitative Concept]
   790   C1705102:Volume [Intellectual Product]
   790   C2700258:Volume [Laboratory Procedure]
   790   C2827736:3+ [Quantitative Concept]
   790   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.185: The extract was filtered, and the residue was extracted again and filtered as before. 

Phrase: "The extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: ","

Phrase: "and"

Phrase: "the residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "again"

Phrase: "and"

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: "as"

Phrase: "before."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]
Processing 00000000.tx.186: The residue was then washed with ethanol, dried under vacuum, and made into a slurry with water. 

Phrase: "The residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with ethanol,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "dried under vacuum,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0042221:Vacuum [Natural Phenomenon or Process]
   790   C1512080:Dried [Qualitative Concept]
   790   C2827485:Dried [Body Substance]
   756 E C0011682:Dry [Natural Phenomenon or Process]
   756 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "made into a slurry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883043:Slurry [Substance]
   737   C1881534:Make [Functional Concept]

Phrase: "with water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.187: It was then exhaustively dialyzed against water at 4C. 

Phrase: "It"

Phrase: "was"

Phrase: "then exhaustively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "dialyzed against water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.188: The sample was lyophilized and then dried under vacuum for 1 day. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "lyophilized"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dried under vacuum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0042221:Vacuum [Natural Phenomenon or Process]
   790   C1512080:Dried [Qualitative Concept]
   790   C2827485:Dried [Body Substance]
   756 E C0011682:Dry [Natural Phenomenon or Process]
   756 E C0205222:Dry [Qualitative Concept]

Phrase: "for 1 day."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1442449:1 Day [Temporal Concept]
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
Processing 00000000.tx.189: Liberation of glycans from glycoproteins by hydrazinolysis Carbohydrate chains were released from glycoproteins by hydrazinolysis at 85C for 12 h, and N-acetylated sugars were re-N-acylated following published procedures (Wing et al., 1992). 

Phrase: "Liberation of glycans"

Phrase: "from glycoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017968:Glycoproteins [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "by hydrazinolysis Carbohydrate chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007004:Carbohydrate [Carbohydrate]
   827   C0337112:chains [Manufactured Object]
   827   C1524075:Chains [Idea or Concept]

Phrase: "were"

Phrase: "released from glycoproteins"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0017968:Glycoproteins [Amino Acid, Peptide, or Protein,Carbohydrate]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by hydrazinolysis"

Phrase: "at 85C"

Phrase: "for 12 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "N-acetylated sugars"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0242209:Sugars [Carbohydrate,Pharmacologic Substance]
   793 E C0007004:Sugar [Carbohydrate]

Phrase: "were"

Phrase: "re-"

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "acylated"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "published procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "(Wing et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.190: Purification of glycans by microcrystalline cellulose column chromatography To remove peptides and amino acids, the preparation was applied to a column of microcrystalline cellulose equilibrated in 1-butanol-ethanol-water, 4:1:0.5 by volume. 

Phrase: "Purification of glycans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243114:purification [Functional Concept]
   790   C1998793:Purification [Functional Concept]

Phrase: "by microcrystalline cellulose column chromatography To"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0684296:Column Chromatography [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "applied to a column of microcrystalline cellulose"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0669247:microcrystalline cellulose [Biomedical or Dental Material,Carbohydrate,Pharmacologic Substance]
   778   C3255827:micro-crystalline cellulose [Pharmacologic Substance]
   748   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   748   C0185125:Applied [Health Care Activity]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]
   748   C3255829:microcrystalline [Pharmacologic Substance]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]

Phrase: "equilibrated in 1-butanol-ethanol-water,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001962:Ethanol [Organic Chemical]
   753   C0001977:Butanol [Lipid]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0089147:butanol [Lipid]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]

Phrase: "4"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "0.5 by volume."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0444499:0/5 [Quantitative Concept]
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.191: Peptides and amino acids were removed by elution with 10 column volumes of 1-butanol-ethanol-water, 4:1:0.5 by volume. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "removed by elution"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0849355:Removed [Qualitative Concept]
   790   C1441565:Elution [Laboratory Procedure]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "with 10 column volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0449468:volumes [Quantitative Concept]
   793 E C1690016:% volume [Qualitative Concept]
   793 E C1705102:Volume [Intellectual Product]
   793 E C2700258:Volume [Laboratory Procedure]

Phrase: "of 1-butanol-ethanol-water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   812   C0599638:WATER [Substance]
   812   C1550678:Water [Inorganic Chemical]
   741 E C0443350:Watery [Qualitative Concept]

Phrase: "4"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "0.5 by volume."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0444499:0/5 [Quantitative Concept]
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.192: The column was then washed with 1 column volume of ethanol, and glycans were recovered by elution with 5 volumes of water. 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with 1 column volume of ethanol,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0001962:Ethanol [Organic Chemical]
   748   C0449468:*Volume [Quantitative Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1548982:Washed [Idea or Concept]
   748   C1690016:% volume [Qualitative Concept]
   748   C1705102:Volume [Intellectual Product]
   748   C1706132:Column [Idea or Concept]
   748   C2700258:Volume [Laboratory Procedure]
   714 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "glycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "recovered by elution"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0521108:recovered [Qualitative Concept]
   790   C1441565:Elution [Laboratory Procedure]
   756 E C2004454:recover [Organism Function]

Phrase: "with 5 volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449468:volumes [Quantitative Concept]
   827 E C1690016:% volume [Qualitative Concept]
   827 E C1705102:Volume [Intellectual Product]
   827 E C2700258:Volume [Laboratory Procedure]

Phrase: "of water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.193: The sample was lyophilized. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "lyophilized."
Processing 00000000.tx.194: The reducing termini of glycans were then quantitatively regenerated in distilled water containing 1 mM Cu (II) acetate and 1 mM acetic acid for 1 h at room temperature. 

Phrase: "The reducing termini of glycans"

Phrase: "were"

Phrase: "then quantitatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "regenerated in distilled water"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0334213:Regenerated [Functional Concept]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mM Cu (II"

Phrase: ")"

Phrase: "acetate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mM acetic acid for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C0000985:Acetic acid [Organic Chemical]
   774   C1121424:H acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.195: Salts were removed with a Dowex AG 50W-X12 (H+) column and then lyophilized. 

Phrase: "Salts"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0036140:Salts [Chemical Viewed Structurally]
   966 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   966 E C0206136:Salt [Food,Inorganic Chemical]
   916 E C1537053:salty [Qualitative Concept]
   893 E C0678584:saltiness [Qualitative Concept]

Phrase: "were"

Phrase: "removed with a Dowex AG 50W-X12"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0058714:Dowex [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0809885:X12 [Quantitative Concept]
   748   C0849355:Removed [Qualitative Concept]
   714 E C1883720:Remove [Activity]
   714 E C3244314:remove [Functional Concept]

Phrase: "(H+) column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "lyophilized."
Processing 00000000.tx.196: Separation of glycans into charged and neutral fractions by anion exchange chromatography Glycans were fractioned into neutral and acidic glycans by anion exchange column chromatography (acetate form). 

Phrase: "Separation of glycans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "into charged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]

Phrase: "and"

Phrase: "neutral fractions by anion exchange chromatography Glycans"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "fractioned into neutral"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1882074:Neutral [Qualitative Concept]
   790   C2825492:Neutral [Phenomenon or Process]
   756   C1264633:Fraction [Quantitative Concept]
   756   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "acidic glycans by anion exchange column chromatography"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]

Phrase: "(acetate form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: ")."
Processing 00000000.tx.197: Neutral glycans were recovered by elution with deionized water, and total acidic fractions were obtained by elution with 2 M ammonia formate. 

Phrase: "Neutral glycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "recovered by elution"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0521108:recovered [Qualitative Concept]
   790   C1441565:Elution [Laboratory Procedure]
   756 E C2004454:recover [Organism Function]

Phrase: "with deionized water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "total acidic fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "obtained by elution"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1441565:Elution [Laboratory Procedure]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with 2 M ammonia formate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016572:formate [Organic Chemical]
   812   C0220832:formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.198: Labeling with ABEE Glycans were labeled with ABEE so that they could be monitored using a UV detector (314 nm): ABEE was dissolved in a freshly prepared mixture of glacial acetic acid/dimethyl sulfoxide (3:7 by volume). 

Phrase: "Labeling with ABEE Glycans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1167624:Labeling [Mental Process]
   744   C1947902:Labeling [Manufactured Object]
   744   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "were"

Phrase: "labeled with ABEE"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0053225:Benzoic Acid [Organic Chemical,Pharmacologic Substance]
           benzoic
   778   C1161334:benzoic acid [Organic Chemical,Pharmacologic Substance]
   774   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0014898:Ester [Organic Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "they"

Phrase: "could"

Phrase: "be"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a UV detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0180392:Detector [Medical Device]
   861   C1705235:Detector [Manufactured Object]

Phrase: "(314 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: ":"

Phrase: "ABEE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0014898:Ester [Organic Chemical]

Phrase: "was"

Phrase: "dissolved in a freshly prepared mixture of glacial acetic acid/dimethyl sulfoxide"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0000983:Glacial Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Acetic Acid
   753   C0000985:Acetic acid [Organic Chemical]
   753   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   736   C0001128:Acid [Chemical]
   736   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   736   C0038771:sulfoxide [Organic Chemical]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0439962:Mixture [Substance]
   736   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   736   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   703   C1549535:Dissolve [Functional Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "7 by volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449468:*Volume [Quantitative Concept]
   790   C1690016:% volume [Qualitative Concept]
   790   C1705102:Volume [Intellectual Product]
   790   C2700258:Volume [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.199: This was added to sodium cyanoborohydride and vortexed thoroughly until all the reductant had dissolved; 

Phrase: "This"

Phrase: "was"

Phrase: "added to sodium cyanoborohydride"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0074738:sodium cyanoborohydride [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   770   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   770   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "vortexed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "thoroughly"

Phrase: "until"

Phrase: "all the reductant"

Phrase: "had"

Phrase: "dissolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549535:Dissolve [Functional Concept]

Phrase: ";"
Processing 00000000.tx.200: 1 ml of this mixture was added to 50 mg dried glycans and incubated at 60C for 4 h. 

Phrase: "1 ml of this mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added to 50 mg dried glycans"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]
   753   C0439269:mg% [Quantitative Concept]
   753   C1512080:Dried [Qualitative Concept]
   753   C1524062:Added [Functional Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C2827485:Dried [Body Substance]
   719 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated at 60C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.201: The samples were spotted onto Whatman 3MM paper strips and allowed to dry at room temperature overnight. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "spotted onto Whatman 3MM paper strips"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030351:Paper [Manufactured Object]
   753   C1321564:strips [Medical Device]
   753   C1547566:Paper [Idea or Concept]
   719   C0329155:Spot [Fish]
   719   C1427618:SPOT [Gene or Genome]
   719   C1705203:Spot [Conceptual Entity]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dry at room temperature overnight."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   760   C0005903:temperature [Organism Attribute]
   760   C0011682:Dry [Natural Phenomenon or Process]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0205222:Dry [Qualitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1512080:Dry [Qualitative Concept]
   760   C1547703:Room [Spatial Concept]
Processing 00000000.tx.202: Excess reagents were removed by ascending paper chromatography in butanol-ethanol-water 4:1:1 by volume. 

Phrase: "Excess reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "removed by ascending paper chromatography"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0008568:Chromatography, Paper [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0030351:Paper [Manufactured Object]
   760   C0205385:Ascending [Qualitative Concept]
   760   C0849355:Removed [Qualitative Concept]
   760   C1547175:Ascending [Functional Concept]
   760   C1547566:Paper [Idea or Concept]
   760   C1962987:Ascending [Functional Concept]
   726 E C0308355:ASCEND [Organic Chemical,Pharmacologic Substance]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "in butanol-ethanol-water 4"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0001962:Ethanol [Organic Chemical]
   812   C0001977:Butanol [Lipid]
   812   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   812   C0089147:butanol [Lipid]
   812   C0599638:WATER [Substance]
   812   C1550678:Water [Inorganic Chemical]
   741 E C0443350:Watery [Qualitative Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 by volume."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0449468:*Volume [Quantitative Concept]
   790   C1690016:% volume [Qualitative Concept]
   790   C1705102:Volume [Intellectual Product]
   790   C2700258:Volume [Laboratory Procedure]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]
Processing 00000000.tx.203: After drying, labeled glycans from the origin were recovered by washing with water. 

Phrase: "After drying,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0011682:drying [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]
   966 E C1512080:Dry [Qualitative Concept]

Phrase: "labeled glycans from the origin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "recovered by washing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0441648:Washing [Activity]
   790   C0521108:recovered [Qualitative Concept]
   756 E C2004454:recover [Organism Function]

Phrase: "with water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.204: Starch is a typical sizing material used in the preparation of paper products. 

Phrase: "Starch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038179:Starch [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "a typical sizing material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "used in the preparation of paper products."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   757   C1524063:Use of [Functional Concept]
   748   C0030351:Paper [Manufactured Object]
   748   C0455052:Preparation [Health Care Activity]
   748   C1273517:used [Finding]
   748   C1514468:Products [Entity]
   748   C1521827:Preparation [Functional Concept]
   748   C1547566:Paper [Idea or Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1704444:Product [Quantitative Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.205: To confirm that this procedure did not lead to the contamination of ABEE-labeled polysaccharides with starch which could be present and eluted from Whatman 3MM paper, strips were incubated in 50 ml H2O while shaking for 8 h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "this procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to the contamination of ABEE-labeled polysaccharides"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   753   C0053225:Benzoic Acid [Organic Chemical,Pharmacologic Substance]
           benzoic
   753   C1161334:benzoic acid [Organic Chemical,Pharmacologic Substance]
   751   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C2917660:Amino Acid [Pharmacologic Substance]
   736   C0001128:Acid [Chemical]
   736   C0014898:Ester [Organic Chemical]
   736   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   736   C0032594:Polysaccharides [Carbohydrate,Pharmacologic Substance]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0259846:contamination [Human-caused Phenomenon or Process]
   736   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   736   C1522538:Lead [Functional Concept]
   736   C1708632:Labeled [Qualitative Concept]
   736   C1881659:CONTAMINATION [Event]
   736   C2348269:Lead [Element, Ion, or Isotope]
   736   C2349974:Contamination [Idea or Concept]
   736   C3275067:LEAD [Therapeutic or Preventive Procedure]
   703 E C0181496:Label [Manufactured Object]
   703 E C2348281:Polysaccharide [Carbohydrate]
   703 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with starch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038179:Starch [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "eluted from Whatman 3MM paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030351:Paper [Manufactured Object]
   760   C1547566:Paper [Idea or Concept]

Phrase: "strips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321564:strips [Medical Device]

Phrase: "were"

Phrase: "incubated in 50 ml H2O"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439526:/mL [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "while"

Phrase: "shaking for 8 h."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0040822:Shaking [Sign or Symptom]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C1883023:Shake [Activity]
Processing 00000000.tx.206: The supernatant was filtered, lyophilized, and examined by NMR spectroscopy. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: ","

Phrase: "lyophilized"

Phrase: ","

Phrase: "and"

Phrase: "examined by NMR spectroscopy."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   882   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   833   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   833   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   833   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   833   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   790   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   790   C1551403:Magnetic resonance [Laboratory Procedure]
   753   C0024488:Magnetic [Occupation or Discipline]
   753   C0037812:spectroscopy [Laboratory Procedure]
   753   C0231881:Resonance [Finding]
   753   C0332128:Examined [Finding]
   753   C0459800:resonance [Natural Phenomenon or Process]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0563532:magnetic [Natural Phenomenon or Process]
   753   C0684213:Resonance [Qualitative Concept]
   753   C2713504:Spectroscopy [Occupation or Discipline]
   753   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.207: No signals were observed corresponding to amylose. 

Phrase: "No signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "corresponding to amylose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002732:Amylose [Carbohydrate]
Processing 00000000.tx.208: Bio-Gel chromatography Size chromatography was performed at room temperature on Bio-Gel columns P4 (120 x 1 cm), P10 (120 x 1 cm), and P60 (110 x 1 cm). 

Phrase: "Bio-Gel chromatography Size chromatography"

Phrase: "was"

Phrase: "performed at room temperature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1547703:Room [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on Bio-Gel columns P4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1539372:p4 [Gene or Genome]

Phrase: "(120 x 1 cm"

Phrase: ")"

Phrase: ","

Phrase: "P10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0966870:p10 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1425194:p10 [Gene or Genome]
  1000   C1548702:P10 [Intellectual Product]

Phrase: "(120 x 1 cm"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "P60"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539537:p60 [Gene or Genome]
  1000   C3540648:p60 [Amino Acid, Peptide, or Protein]

Phrase: "(110 x 1 cm"

Phrase: ")."
Processing 00000000.tx.209: Glycans dissolved in 0.5 ml redistilled water were applied to each column and eluted with redistilled water at a flow rate of 0.2 ml/min, collecting 1.6 ml/tube. 

Phrase: "Glycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032594:Glycans [Carbohydrate,Pharmacologic Substance]

Phrase: "dissolved in 0.5 ml redistilled water"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C0599638:WATER [Substance]
   748   C1550678:Water [Inorganic Chemical]
   714   C1549535:Dissolve [Functional Concept]

Phrase: "were"

Phrase: "applied to each column"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0185125:Applied [Health Care Activity]
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "eluted with redistilled water"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "at a flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 0.2 ml/min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439445:mL/min [Quantitative Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "collecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516698:Collecting [Functional Concept]

Phrase: "1.6 ml/tube."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175730:Tube [Medical Device]
   812   C1547937:Tube NOS [Intellectual Product]
   812   C1561954:tube [Conceptual Entity]
   812   C1704730:TUBE [Medical Device]
Processing 00000000.tx.210: The elution of glycans was monitored with a UV detector at 314 nm. 

Phrase: "The elution of glycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441565:Elution [Laboratory Procedure]

Phrase: "was"

Phrase: "monitored with a UV detector"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0041625:UV [Natural Phenomenon or Process]
   760   C0180392:Detector [Medical Device]
   760   C1705235:Detector [Manufactured Object]
   760   C1961129:uV [Quantitative Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "at 314 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.211: Sugar composition analysis by GC Samples were incubated in 400 l 2 M trifluoroacetic acid at 121C for 2 h and then dried. 

Phrase: "Sugar composition analysis by GC Samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1303103:Sample analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "incubated in 400 l 2 M trifluoroacetic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0040982:Trifluoroacetic Acid [Organic Chemical]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 121C"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dried."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.212: Remaining traces of acid were removed by adding 250 l 2-propanol. 

Phrase: "Remaining traces of acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0442822:Trace [Quantitative Concept]
   737   C1524031:Trace [Qualitative Concept]
   737   C1883002:Trace [Functional Concept]

Phrase: "were"

Phrase: "removed by adding 250 l 2-propanol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   757   C0947272:Add 2 [Quantitative Concept]
   748   C0001964:Propanol [Organic Chemical,Pharmacologic Substance]
   748   C0175804:Propanol [Organic Chemical]
   748   C0849355:Removed [Qualitative Concept]
   714   C1883712:Add [Functional Concept]
   714 E C1883720:Remove [Activity]
   714 E C3244314:remove [Functional Concept]
Processing 00000000.tx.213: The dried hydrolyzed sample was dissolved and incubated in 250 l 1 M ammonium hydroxide containing 10 mg/ml NaBH4 at room temperature for 3 h. 

Phrase: "The dried hydrolyzed sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "dissolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "incubated in 250 l 1 M ammonium hydroxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0051719:ammonium hydroxide [Inorganic Chemical,Pharmacologic Substance]
   744   C0002611:Ammonium [Inorganic Chemical]
   744   C0220853:hydroxide [Element, Ion, or Isotope]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mg/ml NaBH4 at room temperature"

Phrase: "for 3 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.214: Drops of acetic acid were added until effervescing ceased. 

Phrase: "Drops of acetic acid"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0991568:Drops [Biomedical or Dental Material]
   770   C1321095:Drops [Quantitative Concept]
   770   C2347093:drops [Quantitative Concept]
   737 E C1705648:Drop [Activity]
   737 E C2348338:Drop [Quantitative Concept]

Phrase: "were"

Phrase: "added until effervescing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "ceased."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947925:Cease [Activity]
Processing 00000000.tx.215: Borate ions were removed from the dried sample by adding 0.5 ml methanol/acetic acid (9:1 by volume) and drying 7x at room temperature with the last time using only 0.5 ml methanol. 

Phrase: "Borate ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C3256126:BORATE ION [Pharmacologic Substance]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "were"

Phrase: "removed from the dried sample"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0370003:Sample [Substance]
   760   C0849355:Removed [Qualitative Concept]
   760   C1512080:Dried [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]
   760   C2827485:Dried [Body Substance]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "by adding 0.5 ml methanol/acetic acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   818   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   818   C0000985:Acetic acid [Organic Chemical]
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]
   795   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   740 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(9"

Phrase: ":"

Phrase: "1 by volume"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0449468:*Volume [Quantitative Concept]
   790   C1690016:% volume [Qualitative Concept]
   790   C1705102:Volume [Intellectual Product]
   790   C2700258:Volume [Laboratory Procedure]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "drying 7x at room temperature"

Phrase: "with the last time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "only 0.5 ml methanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.216: The sample was acetylated with 0.2 ml pyridine and 0.2 ml acetic anhydride overnight at room temperature and then dried under an N2 stream. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "acetylated with 0.2 ml pyridine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0034251:pyridine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0034255:Pyridine [Organic Chemical]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "0.2 ml acetic anhydride overnight at room temperature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0000986:acetic anhydride [Organic Chemical]
   742   C0003030:Anhydride [Organic Chemical]
   742   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dried under an N2 stream."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0441960:N2 [Finding]
   760   C0442540:Stream [Natural Phenomenon or Process]
   760   C1512080:Dried [Qualitative Concept]
   760   C2827485:Dried [Body Substance]
   726 E C0011682:Dry [Natural Phenomenon or Process]
   726 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.217: A mixture of chloroform and water was added to the sample, followed by vortexing. 

Phrase: "A mixture of chloroform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "was"

Phrase: "added to the sample,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C1524062:Added [Functional Concept]
   770   C2347026:Sample [Conceptual Entity]
   737 E C1883712:Add [Functional Concept]

Phrase: "followed by vortexing."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0439648:vortexing [Spatial Concept]
   790   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   756 E C1719822:Follow [Intellectual Product]
   756 E C2719416:Vortex [Pharmacologic Substance]
Processing 00000000.tx.218: The organic phase was concentrated under a N2 stream and analyzed by GC. 

Phrase: "The organic phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "concentrated under a N2 stream"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0441960:N2 [Finding]
   760   C0442540:Stream [Natural Phenomenon or Process]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "analyzed by GC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008555:Gas Chromatography [Laboratory Procedure]
   770   C0008550:Chromatography [Laboratory Procedure]
   770   C0017110:Gas [Chemical Viewed Structurally]
   770   C0596601:Gas [Sign or Symptom]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.219: GC was performed on a DB-225 fused silica capillary column (0.25 mm x 30 m) using a Hewlett-Packard 5890 J gas chromatograph. 

Phrase: "GC"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008555:Gas Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C0017110:Gas [Chemical Viewed Structurally]
   861   C0596601:Gas [Sign or Symptom]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "was"

Phrase: "performed on a DB-225 fused silica capillary column"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   742   C0006901:Capillary [Body Part, Organ, or Organ Component]
   742   C0037098:Silica [Biomedical or Dental Material,Inorganic Chemical]
   742   C0699952:Fused [Functional Concept]
   742   C0884358:Performed [Functional Concept]
   742   C0935624:Capillary [Body Part, Organ, or Organ Component]
   742   C1185738:Column [Body Part, Organ, or Organ Component]
   742   C1280521:Capillary [Body Part, Organ, or Organ Component]
   742   C1706132:Column [Idea or Concept]
   708 E C1414861:FUSE [Gene or Genome]
   708 E C1708111:Fuse [Manufactured Object]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(0.25 mm x 30"

Phrase: "m)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Hewlett-Packard 5890 J gas chromatograph."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0017110:Gas [Chemical Viewed Structurally]
   799   C0302647:chromatograph [Medical Device]
   799   C0596601:Gas [Sign or Symptom]
   777   C0008555:Gas Chromatographies [Laboratory Procedure]
Processing 00000000.tx.220: The oven temperature was programmed from 180 to 220C at 2C/min. 

Phrase: "The oven temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "was"

Phrase: "programmed from 180"

Phrase: "to 220C"

Phrase: "at 2C/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.221: Methylation linkage analysis Samples were permethylated (Ciucano and Kerek, 1984), hydrolyzed, reduced, and peracetylated according to the procedure of sugar composition analysis by GC. 

Phrase: "Methylation linkage analysis Samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1303103:analysis sample [Laboratory Procedure]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "permethylated"

Phrase: "(Ciucano"

Phrase: "and"

Phrase: "Kerek,"

Phrase: "1984"

Phrase: ")"

Phrase: ","

Phrase: "hydrolyzed"

Phrase: ","

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "peracetylated according to the procedure of sugar composition analysis"

Phrase: "by GC."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008555:Gas Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C0017110:Gas [Chemical Viewed Structurally]
   861   C0596601:Gas [Sign or Symptom]
   761 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.222: The partially methylated alditol acetates were analyzed on a JEOLAX-505 (JEOL USA, Peabody, MA) double-focusing mass spectrometer coupled to a Hewlett-Packard 5890 J gas chromatograph via a heated interface. 

Phrase: "The partially methylated alditol acetates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0000979:Acetates [Organic Chemical,Pharmacologic Substance]
   779 E C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed on a JEOLAX-505"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0936012:Analyzed [Research Activity]

Phrase: "(JEOL USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "Peabody,"

Phrase: "MA)"

Phrase: "double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "focusing mass spectrometer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0183396:Mass Spectrometer [Medical Device]
   827   C0183395:Spectrometer [Medical Device]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C1710143:Spectrometer [Manufactured Object]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "coupled to a Hewlett-Packard 5890 J gas chromatograph"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0017110:Gas [Chemical Viewed Structurally]
   742   C0302647:chromatograph [Medical Device]
   742   C0596601:Gas [Sign or Symptom]
   742   C1948027:Coupled [Functional Concept]
   714   C0008555:Gas Chromatographies [Laboratory Procedure]
   708 E C0010222:couple [Family Group]

Phrase: "via a heated interface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708533:Interface [Manufactured Object]
   861   C2698172:Interface [Intellectual Product]
Processing 00000000.tx.223: GC separation employed a DB-225 fused-silica column (0.25 mm x 30 m). 

Phrase: "GC separation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0036679:Separation [Pathologic Function]
   827   C0237868:Separation [Social Behavior]
   827   C1881713:SEPARATION [Phenomenon or Process]
   734   C0008555:Gas Chromatography [Laboratory Procedure]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a DB-225"

Phrase: "fused-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:Fused [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "silica column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "(0.25 mm x 30"

Phrase: "m)."
Processing 00000000.tx.224: The oven temperature was programmed from 160 to 220C at 5C/min. 

Phrase: "The oven temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "was"

Phrase: "programmed from 160"

Phrase: "to 220C"

Phrase: "at 5C/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.225: The relative abundance of the partially methylated alditol acetates was determined by GC analysis on a Hewlett-Packard 5890 gas chromatography equipped with a DB-225 capillary column and flame ionization detector. 

Phrase: "The relative abundance of the partially methylated alditol acetates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2346714:Abundance [Qualitative Concept]

Phrase: "was"

Phrase: "determined by GC analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0008555:Gas Chromatography [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0017110:Gas [Chemical Viewed Structurally]
   760   C0596601:Gas [Sign or Symptom]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "on a Hewlett-Packard 5890 gas chromatography"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0008555:Gas Chromatography [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0017110:Gas [Chemical Viewed Structurally]
   804   C0596601:Gas [Sign or Symptom]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "equipped with a DB-225 capillary column"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0006901:Capillary [Body Part, Organ, or Organ Component]
   748   C0935624:Capillary [Body Part, Organ, or Organ Component]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1280521:Capillary [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "flame ionization detector."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0016197:Flame Ionization [Laboratory Procedure]
   827   C0180392:Detector [Medical Device]
   827   C0596801:Ionization [Phenomenon or Process]
   827   C1413357:FLAME [Gene or Genome]
   827   C1705235:Detector [Manufactured Object]
   827   C3272498:FLAME [Gene or Genome]
Processing 00000000.tx.226: The oven temperature was programmed from 180 to 220C at 2C/min. 

Phrase: "The oven temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "was"

Phrase: "programmed from 180"

Phrase: "to 220C"

Phrase: "at 2C/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.227: Helium was the carrier gas for both GC methods. 

Phrase: "Helium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018880:Helium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "the carrier gas for both GC methods."
Processing 00000000.tx.228: 500 MHz proton NMR spectrometry The glycan sample was exchanged 3x with D2O (99.9 atom% D) by lyophilization and finally dissolved in D2O (99.996 atom% D). 

Phrase: "500 MHz proton NMR spectrometry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0678652:magnetic resonance spectrometry [Laboratory Procedure]
   795   C0436196:Spectrometry [Laboratory Procedure]

Phrase: "The glycan sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "exchanged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678640:exchange [Social Behavior]

Phrase: "3x with D2O"

Phrase: "(99.9 atom%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0567415:Atom [Element, Ion, or Isotope]
   827   C1706222:Atom [Conceptual Entity]

Phrase: "D) by lyophilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016698:Lyophilization [Laboratory Procedure]
   790   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "finally"

Phrase: "dissolved in D2O"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]

Phrase: "(99.996 atom%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0567415:Atom [Element, Ion, or Isotope]
   827   C1706222:Atom [Conceptual Entity]

Phrase: "D)."
Processing 00000000.tx.229: The 500 MHz 1H NMR spectrum was obtained with a Varian VXR 500 spectrometer operating in the Fourier transform mode at a probe temperature of 50C. 

Phrase: "The 500 MHz 1H NMR spectrum"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   845   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   845   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   845   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   818   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   818   C1551403:Magnetic resonance [Laboratory Procedure]
   795   C0024488:Magnetic [Occupation or Discipline]
   795   C0231881:Resonance [Finding]
   795   C0459800:resonance [Natural Phenomenon or Process]
   795   C0521447:Nuclear [Spatial Concept]
   795   C0563532:magnetic [Natural Phenomenon or Process]
   795   C0684213:Resonance [Qualitative Concept]
   795   C1883073:Spectrum [Quantitative Concept]
   795   C2827424:Spectrum [Conceptual Entity]
   724 E C0024483:Magnet [Manufactured Object]
   724 E C0577554:Resonant [Qualitative Concept]
   724 E C0885556:magnets [Pharmacologic Substance]
   724 E C1706318:Magnet [Manufactured Object]

Phrase: "was"

Phrase: "obtained with a Varian VXR 500 spectrometer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0183395:Spectrometer [Medical Device]
   748   C1301820:Obtained [Functional Concept]
   748   C1710143:Spectrometer [Manufactured Object]
   714 E C1706701:Obtain [Activity]

Phrase: "operating in the Fourier transform mode"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282183:Fourier Transform [Quantitative Concept]
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]
   719   C3242339:operate [Functional Concept]

Phrase: "at a probe temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "of 50C."
Processing 00000000.tx.230: Chemical shifts were expressed in ppm from acetone (2.225 ppm). 

Phrase: "Chemical shifts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220806:Chemical [Chemical]
   861   C0333051:shifts [Functional Concept]
   861   C3272558:Chemical [Intellectual Product]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "expressed in ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439187:ppm [Quantitative Concept]

Phrase: "from acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: "(2.225 ppm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439187:ppm [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.231: Histology Paraffin sections of AD cortex were deparaffinized using xylene and then rehydrated through an ethanol series into water. 

Phrase: "Histology Paraffin sections of AD cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "deparaffinized"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "xylene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rehydrated through an ethanol series"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001962:Ethanol [Organic Chemical]
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "into water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.232: The sections were then stained for 0/5 h in 2% potassium iodide/1% iodine dissolved in water. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained for 0/5 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0444499:0/5 [Quantitative Concept]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in 2% potassium iodide/1% iodine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0982235:potassium iodine [Inorganic Chemical,Pharmacologic Substance]
   804   C0021966:Iodine- [Inorganic Chemical]
   804   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0885449:iodine [Pharmacologic Substance]
   804   C2348268:Iodine [Element, Ion, or Isotope]

Phrase: "dissolved in water."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   756   C1549535:Dissolve [Functional Concept]
   718 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.233: After a brief rinse with 0.1 N H2SO4, the sections were embedded in a mixture of glycerol, staining solution, and acid (5 cc glycerol/5 cc staining solution/1 cc 0.1 N H2S04). 

Phrase: "After a brief rinse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1701810:Rinse [Functional Concept]
   861   C1882955:Rinse [Activity]

Phrase: "with 0.1 N H2SO4,"

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "embedded in a mixture of glycerol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0439962:Mixture [Substance]
   753   C1707903:Embedded [Laboratory Procedure]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "solution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001128:Acid [Chemical]
  1000   C0202406:Acid [Laboratory Procedure]

Phrase: "(5 cc glycerol/5 cc staining solution/1 cc 0.1 N H2S04"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   707   C3202978:5-1-1 [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.234: The senile plaques were imaged on a Nikon DXM1200 digital camera using 10x and 100x objectives.  

Phrase: "The senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "were"

Phrase: "imaged on a Nikon DXM1200 digital camera"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0179533:Camera [Medical Device]
   748   C0442015:Digital [Intellectual Product]
   748   C1654607:Camera [Eukaryote]
   748   C1706254:CAMERA [Medical Device]
   748   C1883674:Digital [Qualitative Concept]
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10x"

Phrase: "and"

Phrase: "100x objectives."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018017:objectives [Intellectual Product]
   827 E C1571702:Objective [Qualitative Concept]
Processing 00000000.tx.235: Acknowledgements  This work was supported by National Institutes of Health grant NS25117. 

Phrase: "Acknowledgements"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health grant NS25117."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grant [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]
Processing 00000000.tx.236: We thank Melissa Bugg for critical reading of the manuscript.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Melissa Bugg for critical reading of the manuscript."
Processing 00000000.tx.237: Footnotes  1 To whom correspondence should be addressed; 

Phrase: "Footnotes  1 To whom correspondence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0282413:Correspondence [Intellectual Product]
   726   C2825232:Footnote [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.238: e-mail: zipserb{at}msu.edu  Abbreviations  A, amyloid- peptide; 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "zipserb{at}msu.edu  Abbreviations  A,"

Phrase: "amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.239: ABEE, aminobenzoic acid ethyl ester; 

Phrase: "ABEE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0014898:Ester [Organic Chemical]

Phrase: "aminobenzoic acid ethyl ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014898:Ester [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.240: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.241: GC, gas chromatography; 

Phrase: "GC,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008555:Gas Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C0017110:Gas [Chemical Viewed Structurally]
   861   C0596601:Gas [Sign or Symptom]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "gas chromatography"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008555:Gas Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C0017110:Gas [Chemical Viewed Structurally]
   861   C0596601:Gas [Sign or Symptom]
   761 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.242: MS, mass spectrometry; 

Phrase: "MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2349943:Ms. [Conceptual Entity]
  1000   C3539704:MS [Gene or Genome]

Phrase: "mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.243: NMR, nuclear magnetic resonance  References Top Abstract Introduction Results Discussion Materials and methods References  Bigl, M., Bruckner, M.K., Arendt, T., Bigl, V., and Eschrich, K. 

Phrase: "NMR,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
  1000   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
  1000   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "nuclear magnetic resonance"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
  1000   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
  1000   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bigl,"

Phrase: "M."

Phrase: ","

Phrase: "Bruckner,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Arendt,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bigl,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Eschrich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.244: (1999) Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Activities of key glycolytic enzymes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   764   C0243102:enzyme activity [Molecular Function]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.245: J. 

Phrase: "J."
Processing 00000000.tx.246: Neural Transm., 106, 499511.[CrossRef][ISI] Blanc, E.M., Toborek, M., Mark, R.J., Hennig, B., and Mattson, M.P. 

Phrase: "Neural Transm.,"

Phrase: "106,"

Phrase: "499511."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Blanc,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Toborek,"

Phrase: "M."

Phrase: ","

Phrase: "Mark,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]
   928 E C1706089:Marked [Qualitative Concept]

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hennig,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.247: (1997) Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Amyloid beta-peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell monolayer albumin permeability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0031164:Permeability [Natural Phenomenon or Process]
   741 E C0205326:Permeable [Functional Concept]

Phrase: "impairs"

Phrase: "glucose transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in vascular endothelial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3156636:endothelial cell apoptosis [Cell Function]
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.248: J. 

Phrase: "J."
Processing 00000000.tx.249: Neurochem., 68, 18701881.[ISI][Medline] Cavanagh, J.B. 

Phrase: "Neurochem.,"

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "18701881."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cavanagh,"

Phrase: "J.B."
Processing 00000000.tx.250: (1999) Corpora-amylacea and the family of polyglucosan diseases. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Corpora-amylacea"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333564:Corpora amylacea [Pathologic Function]
  1000   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   827   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the family of polyglucosan diseases."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C0344339:disease family [Finding]
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]
   745 E C0277558:Familial disease [Disease or Syndrome]
Processing 00000000.tx.251: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.252: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.253: Rev., 29, 265295.[ISI][Medline] Choi, I.-Y., Seaquist, E.R., and Gruetter, R. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "29,"

Phrase: "265295."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Choi,"

Phrase: "I.-Y.,"

Phrase: "Seaquist,"

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Gruetter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.254: (2003) Effect of hypoglycemia on brain glycogen metabolism in vivo. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Effect of hypoglycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   822   C2936720:Hypoglycemic Effect [Physiologic Function]
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on brain glycogen metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0596215:brain metabolism [Organ or Tissue Function]
   901   C0599784:glycogen metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.255: J. 

Phrase: "J."
Processing 00000000.tx.256: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.257: Res., 72, 2532.[CrossRef][ISI][Medline] Ciucano, I. and Kerek, F. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "72,"

Phrase: "2532."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ciucano,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Kerek,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.258: (1984) A simple and rapid method for the permethylation of carbohydrates. 

Phrase: "(1984"

Phrase: ")"

Phrase: "A simple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205352:Simple [Qualitative Concept]

Phrase: "and"

Phrase: "rapid method for the permethylation of carbohydrates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0872257:rapid method [Diagnostic Procedure]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.259: Carbohydr. 

Phrase: "Carbohydr."
Processing 00000000.tx.260: Res., 131, 209217.[CrossRef][ISI] Cruz, N.F. and Dienel, G.A. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "131,"

Phrase: "209217."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Cruz,"

Phrase: "N.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Dienel,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.261: (2002) High glycogen levels in brains of rats with minimal environmental stimuli: implications for metabolic contributions of working astrocytes. 

Phrase: "(2002"

Phrase: ")"

Phrase: "High glycogen levels in brains of rats"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "with minimal environmental stimuli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0450025:Environmental stimuli [Natural Phenomenon or Process]
   827   C0234402:Stimuli [Phenomenon or Process]

Phrase: ":"

Phrase: "implications for metabolic contributions of working astrocytes."
Processing 00000000.tx.262: J. 

Phrase: "J."
Processing 00000000.tx.263: Cereb. 

Phrase: "Cereb."
Processing 00000000.tx.264: Blood Flow Metab., 22, 14761489.[CrossRef][ISI][Medline] Gasparini, L., Gouras, G.K., Wang, R., Gross, R.S., Beal, M.F., Greengard, P., and Xu, H. 

Phrase: "Blood Flow Metab.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0232338:Blood flow [Organism Function]

Phrase: "22,"

Phrase: "14761489."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gasparini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gouras,"

Phrase: "G.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439806:Gross [Qualitative Concept]

Phrase: "R.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Beal,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Xu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.265: (2001) Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Stimulation of beta-amyloid precursor protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]
   716   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]

Phrase: "trafficking by insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0599896:trafficking [Cell Function]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reduces"

Phrase: "intraneuronal beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "requires"

Phrase: "mitogen-activated protein kinase signaling."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.266: J. 

Phrase: "J."
Processing 00000000.tx.267: Neurosci., 21, 25612570.[Abstract/Free FullText] Gilles-Pierlet, M. 

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "25612570."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gilles-Pierlet,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.268: (1980) Retrogression of the metabolic activity of astrocytes after extinction of an experimental epileptogenic focus. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Retrogression of the metabolic activity of astrocytes"

Phrase: "after extinction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015347:extinction [Mental Process]

Phrase: "of an experimental epileptogenic focus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205234:Focus [Spatial Concept]
   827   C1285542:focus [Functional Concept]
Processing 00000000.tx.269: Histochemical investigation. 

Phrase: "Histochemical investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.270: C.R. 

Phrase: "C.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.271: Seances Soc. 

Phrase: "Seances Soc."
Processing 00000000.tx.272: Biol. 

Phrase: "Biol."
Processing 00000000.tx.273: Fil., 173, 11571162.[ISI][Medline] Hampel, H., Teipel, S.J., Alexander, G.E., Pogarell, O., Rapoport, S.I., and Moeller, H.-J. 

Phrase: "Fil.,"

Phrase: "173,"

Phrase: "11571162."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hampel,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Teipel,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "G.E.,"

Phrase: "Pogarell,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Rapoport,"

Phrase: "S.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Moeller,"

Phrase: "H.-J."
Processing 00000000.tx.274: (2002) In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging of region"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0011923:Imaging [Diagnostic Procedure]
   790   C0017446:Region [Geographic Area]
   790   C0079595:Imaging [Diagnostic Procedure]
   790   C0205147:Region [Spatial Concept]
   756 E C1704254:Image [Intellectual Product]
   756 E C1704922:Image [Entity]
   756 E C3542466:Image [Intellectual Product]
   718 E C0205276:Regional [Spatial Concept]
   718 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "cell type specific neocortical neurodegeneration in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.275: J. 

Phrase: "J."
Processing 00000000.tx.276: Neural Transm., 109, 837855.[CrossRef][ISI] Kajihara, H., Tsutsumi, E., Kinoshita, A., Nakano, J., Takagi, K., and Takeo, S. 

Phrase: "Neural Transm.,"

Phrase: "109,"

Phrase: "837855."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Kajihara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tsutsumi,"

Phrase: "E.,"

Phrase: "Kinoshita,"

Phrase: "A.,"

Phrase: "Nakano,"

Phrase: "J.,"

Phrase: "Takagi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takeo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.277: (2001) Activated astrocytes with glycogen accumulation in ischemic penumbra during the early stage of brain infarction: immunohistochemical and electron microscopic studies. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Activated astrocytes with glycogen accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004112:Astrocytes [Cell]

Phrase: "in ischemic penumbra"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1823520:PENUMBRA [Gene or Genome]

Phrase: "during the early stage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517886:Early Stage [Classification]
  1000   C2363430:Early stage [Temporal Concept]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "of brain infarction"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0751955:Brain Infarction [Disease or Syndrome]
   861   C0021308:Infarction [Pathologic Function]
   789 E C0333541:Infarcted [Functional Concept]

Phrase: ":"

Phrase: "immunohistochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441616:Immunohistochemical [Laboratory Procedure]

Phrase: "and"

Phrase: "electron microscopic studies."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   966   C0026019:Electron microscopic study [Laboratory Procedure]
           Electron Microscopy
   865   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   827   C0013852:Electron [Quantitative Concept]
   827   C0205288:Microscopic [Qualitative Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C3463986:Electron [Bird]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0026018:Microscopies [Laboratory Procedure]
   755 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.278: Brain Res., 909, 92101.[CrossRef][ISI][Medline] Kong, J., Shepel, P.N., Holden, C.P., Mackiewicz, M., Pack, A.I., and Geiger, J.D. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "909,"

Phrase: "92101."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kong,"

Phrase: "J.,"

Phrase: "Shepel,"

Phrase: "P.N.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Holden,"

Phrase: "C.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Mackiewicz,"

Phrase: "M."

Phrase: ","

Phrase: "Pack,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1968515:Pack [Medical Device]
  1000   C2825051:Pack [Drug Delivery Device]
  1000   C2828395:Pack [Activity]

Phrase: "A.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Geiger,"

Phrase: "J.D."
Processing 00000000.tx.279: (2002) Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "decreases with increased periods of wakefulness"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0043012:Wakefulness [Mental Process]
   753   C0205217:Increased [Quantitative Concept]
   753   C0392756:Decrease [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0547047:Decrease [Quantitative Concept]
   719   C0439531:/period [Temporal Concept]
   719   C1948053:Period [Temporal Concept]

Phrase: ":"

Phrase: "implications for homeostatic drive to"

Phrase: "sleep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037313:Sleep [Organism Function]
Processing 00000000.tx.280: J. 

Phrase: "J."
Processing 00000000.tx.281: Neurosci., 22, 55815587.[Abstract/Free FullText] Kurt, M.A., Davies, D.C., and Kidd, M. 

Phrase: "Neurosci.,"

Phrase: "22,"

Phrase: "55815587."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kurt,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Davies,"

Phrase: "D.C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Kidd,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.282: (1999) Beta-amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Beta-amyloid immunoreactivity in astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "in Alzheimer's disease brain biopsies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C0740294:Brain Biopsy [Diagnostic Procedure]
   812   C0005558:biopsies [Diagnostic Procedure]
   779 E C0220797:biopsy [Functional Concept]

Phrase: ":"

Phrase: "an electron microscope study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
   734   C0181845:Electron Microscope [Medical Device]
Processing 00000000.tx.283: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.284: Neurol., 158, 221228.[CrossRef][ISI][Medline] Magistretti, P.J. and Pellerin, L. 

Phrase: "Neurol.,"

Phrase: "158,"

Phrase: "221228."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Magistretti,"

Phrase: "P.J."

Phrase: "and"

Phrase: "Pellerin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.285: (1999) Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cellular mechanisms of brain energy metabolism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "their relevance to functional brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "imaging."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.286: Philos. 

Phrase: "Philos."
Processing 00000000.tx.287: Trans. 

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.288: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.289: Soc. 

Phrase: "Soc."
Processing 00000000.tx.290: Lond. 

Phrase: "Lond."
Processing 00000000.tx.291: B Biol. 

Phrase: "B Biol."
Processing 00000000.tx.292: Sci., 354, 11551163.[CrossRef][ISI][Medline] Magistretti, P.J., Sorg, O., and Martin, J.-L. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "354,"

Phrase: "11551163."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Magistretti,"

Phrase: "P.J.,"

Phrase: "Sorg,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Martin,"

Phrase: "J.-L."
Processing 00000000.tx.293: (1993) Regulation of glycogen metabolism in astrocytes: physiological, pharmacological, and pathological aspects. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Regulation of glycogen metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2753952:regulation of glycogen metabolism [Molecular Function]
   881   C1159402:regulation of metabolism [Organism Function]
           metabolism regulation
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: ":"

Phrase: "physiological, pharmacological,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   861   C0205464:pharmacological [Functional Concept]
   789 E C1524059:pharmacology [Functional Concept]

Phrase: "and"

Phrase: "pathological aspects."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205469:Pathological aspects [Functional Concept]
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.294: In Murphy, S. 

Phrase: "In Murphy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.295: (Ed.), Astrocytes: pharmacology and function. 

Phrase: "(Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: ":"

Phrase: "pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.296: Academic Press, San Diego, pp. 

Phrase: "Academic Press,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "pp."
Processing 00000000.tx.297: 243265. 

Phrase: "243265."
Processing 00000000.tx.298: Mattson, M.P. 

Phrase: "Mattson,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.299: (1998) Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Modification of ion homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "by lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: ":"

Phrase: "roles in neuronal degeneration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "adaptive plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]
Processing 00000000.tx.300: Trends Neurosci., 21, 5357.[CrossRef][ISI][Medline] Mattson, M., Pederson, W., Duan, W., Culmsee, C., and Camandola, S. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "5357."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattson,"

Phrase: "M."

Phrase: ","

Phrase: "Pederson,"

Phrase: "W.,"

Phrase: "Duan,"

Phrase: "W.,"

Phrase: "Culmsee,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Camandola,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.301: (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "perturbed energy metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0014272:Energy Metabolism [Physiologic Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]

Phrase: "and"

Phrase: "neuronal degeneration in Alzheimer's"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "Parkinson's diseases."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0030567:Parkinson Disease [Disease or Syndrome]
   983   C1521736:Parkinson's Disease [Functional Concept]
   983   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.302: Ann. 

Phrase: "Ann."
Processing 00000000.tx.303: NY Acad. 

Phrase: "NY Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.304: Sci., 893 154175.[Abstract/Free FullText] Meeks, J.P. and Mennerick, S. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "893 154175."

Phrase: "[Abstract/Free FullText"

Phrase: "] Meeks,"

Phrase: "J.P."

Phrase: "and"

Phrase: "Mennerick,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.305: (2003) Feeding hungry neurons: astrocytes deliver food for thought. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Feeding hungry neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "food for thought."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016452:Food [Food]
Processing 00000000.tx.306: Neuron, 37, 187189.[CrossRef][ISI][Medline] Pellerin, L., Stolz, M., Sorg, O., Martin, J.L., Deschepper, C.F., and Magistretti, P.J. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "37,"

Phrase: "187189."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pellerin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Stolz,"

Phrase: "M."

Phrase: ","

Phrase: "Sorg,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Martin,"

Phrase: "J.L., Deschepper,"

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Magistretti,"

Phrase: "P.J."
Processing 00000000.tx.307: (1997) Regulation of energy metabolism by neurotransmitters in astrocytes in primary culture and in an immortalized cell line. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Regulation of energy metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1159402:regulation of metabolism [Organism Function]
           metabolism regulation
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by neurotransmitters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]

Phrase: "in astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "in primary culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0010453:Culture [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and in an immortalized cell line."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0007600:Cell Line [Cell]
   790   C0178708:immortalized cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2826170:Immortalized [Molecular Biology Research Technique]
Processing 00000000.tx.308: Glia, 21, 7483.[CrossRef][ISI][Medline] Peters, A., Palay, S.L., and de Webster, H.F. 

Phrase: "Glia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "21,"

Phrase: "7483."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Peters,"

Phrase: "A.,"

Phrase: "Palay,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "de Webster,"

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.309: (1970) The fine structure of the nervous system. 

Phrase: "(1970"

Phrase: ")"

Phrase: "The fine structure of the nervous system."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0027763:Structure of nervous system [Body System]
           Nervous system structure
   748   C0205232:Fine [Qualitative Concept]
   748   C0678594:Structure [Spatial Concept]
   748   C0687757:fine [Regulation or Law]
   716   C0027740:Nerve structure [Tissue]
Processing 00000000.tx.310: Harper & Row, New York. 

Phrase: "Harper & Row,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552846:Row [Idea or Concept]

Phrase: "New York."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]
Processing 00000000.tx.311: Qiu, W.Q., Walsh, D.M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M.B., Rosner, M.R., Safavi, A., Hersh, L.B., and Selkoe, D.J. 

Phrase: "Qiu,"

Phrase: "W.Q., Walsh,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Podlisny,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rosner,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Safavi,"

Phrase: "A.,"

Phrase: "Hersh,"

Phrase: "L.B.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.312: (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "extracellular levels of amyloid beta-protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "by degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.313: J. 

Phrase: "J."
Processing 00000000.tx.314: Biol. 

Phrase: "Biol."
Processing 00000000.tx.315: Chem., 273, 3273032738.[Abstract/Free FullText] Rapoport, S.I. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "3273032738."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rapoport,"

Phrase: "S.I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.316: (1999) Functional brain imaging in the resting state and during activation in Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Functional brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "imaging in the resting state"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   806   C0679218:Resting state [Finding]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0035253:Resting [Daily or Recreational Activity]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1512899:resting [Cell]
   760   C3148680:State [Geographic Area]
   726 E C1622890:ResT [Molecular Function]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "and during activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C1879547:Activation [Activity]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.317: Implications for disease mechanisms involving oxidative phosphorylation. 

Phrase: "Implications for disease mechanisms"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "oxidative phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030013:Oxidative Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0311404:Oxidative [Functional Concept]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.318: Ann. 

Phrase: "Ann."
Processing 00000000.tx.319: NY Acad. 

Phrase: "NY Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.320: Sci., 893, 138153.[Abstract/Free FullText] Razay, G. and Wilcock, G.K. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "893,"

Phrase: "138153."

Phrase: "[Abstract/Free FullText"

Phrase: "] Razay,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wilcock,"

Phrase: "G.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.321: (1994) Hyperinsulinaemia and Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Hyperinsulinaemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.322: Age Ageing, 23, 396399.[Abstract] Sakai, M., Austin, J., Witmer, F., and Trueb, L. 

Phrase: "Age Ageing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "396399."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sakai,"

Phrase: "M."

Phrase: ","

Phrase: "Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "J.,"

Phrase: "Witmer,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Trueb,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.323: (1969) Studies of corpora amylacea I. 

Phrase: "(1969"

Phrase: ")"

Phrase: "Studies of corpora amylacea I."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0333564:Corpora amylacea [Pathologic Function]
   806   C1235668:Corpora amylacea [Body Part, Organ, or Organ Component]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C2603343:Study [Research Activity]
   726   C0227813:Corpus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.324: Isolation and preliminary characterization by chemical and histochemical techniques. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "preliminary characterization by chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0243175:chemical characterization [Classification]
   770   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "histochemical techniques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.325: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.326: Neurol., 21, 526544.[CrossRef][ISI][Medline] Seaquist, E.R., Damberg, G.S., Tkac, I., and Gruetter, R. 

Phrase: "Neurol.,"

Phrase: "21,"

Phrase: "526544."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seaquist,"

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Damberg,"

Phrase: "G.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tkac,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Gruetter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.327: (2001) The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on in vivo cerebral glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   823   C0427743:Glucose concentration [Laboratory Procedure]
   823   C1287281:Glucose concentration [Laboratory or Test Result]
   804   C0086045:Concentrations [Mental Process]
   771 E C1446561:Concentration [Quantitative Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "rates of glucose transport/metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.328: Diabetes, 50, 22032209.[Abstract/Free FullText] Swanson, R.A., Morton, M.M., Sagar, S.M., and Sharp, F.R. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "50,"

Phrase: "22032209."

Phrase: "[Abstract/Free FullText"

Phrase: "] Swanson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Morton,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Sagar,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Sharp, F.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.329: (1992) Sensory stimulation induces local cerebral glycogenolysis: demonstration by autoradiography. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Sensory stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0150763:Sensory stimulation [Therapeutic or Preventive Procedure]
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "local cerebral glycogenolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596624:Glycogenolysis [Molecular Function]

Phrase: ":"

Phrase: "demonstration by autoradiography."
Processing 00000000.tx.330: Neuroscience, 51, 451461.[CrossRef][ISI][Medline] Swanson, R.A., Sagar, S.M., and Sharp, F.R. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "51,"

Phrase: "451461."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Swanson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Sagar,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Sharp, F.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.331: (1989) Regional brain glycogen stores and metabolism during complete global ischaemia. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Regional brain glycogen stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1698986:Store [Functional Concept]

Phrase: "and"

Phrase: "metabolism during complete global ischaemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.332: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.333: Res., 11, 2428.[Medline] Vanucci, S.J., Clark, R.R., Koehler-Stec, E., Li, K., Smith, C.B., Davies, P., Maher, F., and Simpson, I.A. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "11,"

Phrase: "2428."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vanucci,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Clark,"

Phrase: "R.R.,"

Phrase: "Koehler-Stec,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0580794:STEC [Bacterium]
   861   C3264593:STEC NOS [Disease or Syndrome]

Phrase: "E.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Maher,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Simpson,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A."
Processing 00000000.tx.334: (1998) Glucose transporter expression in brain: relationship to cerebral glucose utilization. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Glucose transporter expression in brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "relationship to cerebral glucose utilization."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.335: Dev. 

Phrase: "Dev."
Processing 00000000.tx.336: Neurosci., 20, 369379.[CrossRef][ISI][Medline] Watson, G.S. and Craft, S. 

Phrase: "Neurosci.,"

Phrase: "20,"

Phrase: "369379."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "G.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Craft,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870369:craft [Manufactured Object]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.337: (2003) The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The role of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "implications for treatment."
Processing 00000000.tx.338: CNS Drugs, 17, 2745.[ISI][Medline] Wing, D.R., Rademacher, T.W., Fields, M.C., Dwek, R.A., Schmitz, B., Thor, G., and Schachner, M. 

Phrase: "CNS Drugs,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0007680:CNS DRUGS [Pharmacologic Substance]
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "17,"

Phrase: "2745."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wing,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0043189:Wing [Body Part, Organ, or Organ Component]
   944 E C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rademacher,"

Phrase: "T.W., Fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   793   C1521738:Field [Conceptual Entity]
   793   C2346620:Field [Conceptual Entity]
   793   C2349184:Field [Conceptual Entity]
   793   C3539073:FIELD [Spatial Concept]

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dwek,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Schmitz,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Thor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2785245:Thor [Eukaryote]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Schachner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.339: (1992) Using of large-scale hydrazinolysis in the preparation of N-linked oligosaccharide libraries: application to brain tissue. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Using of large-scale hydrazinolysis"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C1524063:Use of [Functional Concept]
           Using
   760   C0175659:Scale [Medical Device]
   760   C0349674:Scale [Intellectual Product]
   760   C0549177:Large [Quantitative Concept]
   760   C1947916:Scale [Activity]
   760   C3536777:Scale [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "in the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of N-linked oligosaccharide libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0023621:Libraries [Manufactured Object,Organization]
   779 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   779 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "application to brain tissue."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.340: Glycoconj. 

Phrase: "Glycoconj."
Processing 00000000.tx.341: J., 9, 293301.[ISI][Medline] This Article Abstract FREE Full Text (PDF) All Versions of this Article: 14/5/409 most recent cwh042v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Disclaimer Request Permissions Google Scholar Articles by Huang, L. 

Phrase: "J.,"

Phrase: "9,"

Phrase: "293301."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract FREE Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "14/5/409 most recent cwh042v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Disclaimer Request Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706852:Article [Intellectual Product]

Phrase: "by Huang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.342: Articles by Zipser, B. 

Phrase: "Articles by Zipser,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.343: PubMed PubMed Citation Articles by Huang, L. 

Phrase: "PubMed PubMed Citation Articles by Huang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.344: Articles by Zipser, B. 

Phrase: "Articles by Zipser,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.345: Online ISSN 1460-2423 - Print ISSN 0959-6658 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1460-2423 - Print ISSN 0959-6658 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

